{
    "id": "cosaxqs6wukmfiry7h5xixpo2o5aiico",
    "title": "Progressive myoclonus epilepsies \u2013 on the way to precision medicine?",
    "info": {
        "author": [
            "Anna-Elina Lehesjoki, Neuroscience Center (NC), University of Helsinki"
        ],
        "published": "Sept. 22, 2017",
        "recorded": "September 2017",
        "category": [
            "Top->Medicine"
        ]
    },
    "url": "http://videolectures.net/kolokviji_lehesjoki_myoclonus_epilepsies/",
    "segmentation": [
        [
            "Good afternoon, I think it shows that this is the first colloquium out there.",
            "The new the academic year, the new season, the first speaker is professor on Eileena Legacy.",
            "Okie, from from Finland she got her MD.",
            "From the University of Helsinki in 85 and then she got a PhD in medicine from the University of Helsinki in 89 and then a PhD in medical molecular genetics, also from the University of Helsinki in 97.",
            "She held many positions from being a research fellow and then a research associate at the University of Helsinki.",
            "Then the scientists would be Academy of Finland.",
            "Then she was a visiting research associate at the University of California at San Francisco.",
            "Then a senior fellow at University of Helsinki and so on.",
            "The list is pretty long, but currently she is research director and professor at the Neuroscience Center at the University of Helsinki since 2003, and then since 2004 and six she's head of Focus on Institute of Genetics and Research Center, respectively.",
            "And since 2013, she's group leader at the Molecular Neurology Research Program, Faculty of Medicine, University of Helsinki, Domain research topics.",
            "Of Professor Li, his Yorkie revolve around the understanding of molecular basis of epilepsy syndromes through identification of underlying defective genes followed by functional analysis of gene products and characterization of disease mechanisms in cellular and animal models, and today she is going to tell us about her recent and perhaps some more established results.",
            "Thank you very much for the introduction and thank you Natasha for inviting me and it's allowing me to visit for the first time.",
            "The beautiful city of Ljubljana so has pretty much already told me I have a background in human molecular genetics alot and I have been happy to witness the revolution in the Human Genetics research during the past two decades thanks to the Human Genome Project.",
            "So the progress has been enormous and we have witnessed.",
            "A significant progress in understanding the genetic basis of human inherited diseases, especially in rare diseases.",
            "My own interest has been in in epilepsy syndromes, especially in different form of forms of progress in microns, epilepsies, and of course, when we're doing molecular genetics research, we have always the patient behind, so we want to find a diagnosis by finding a gene and then from gene going forward to understand function of the gene product mechanisms of the disease, and then then in the end.",
            "Two to produce new treatments for the patients because they are really expecting it so."
        ],
        [
            "Today I'm going to talk about progressive microns epilepsies, with the question of we on the way to precision medicine, and I have outlined my talk so that I will first define what is progressive myoclonus epilepsy, and then I showed the tell you about the evolution of how understanding of molecular genetics of PPMS or burgers in my Kronos epilepsies hackerd, and then I will tell you about our recent molecular genetics work that resulted in identification of the new PMS syndrome.",
            "And then quite a lot of time of my reaches I will tell about.",
            "One specific PME and that has been a major interest of my research for many years and also interest in this Institute."
        ],
        [
            "So progressive myoclonic epilepsy is they are group of diseases.",
            "Rare genetic epilepsies.",
            "They are rare.",
            "The overall prevalence is approximately one in ten 100,000 individuals, but we are.",
            "We have a variation due to founder effects.",
            "For example, in Finland we have a peculiar population history, and in Finland we have a prevalence of one in 25,000 individuals of PMS.",
            "So it's a heterogeneous group.",
            "Many causes many different prognosis, different clinical manifestations, and also different costs.",
            "But they all patients share a triad of symptoms.",
            "They all have this myoclonic seizures, which are involuntary twitches of muscles, and especially something that is called action myoclonus, which means that when they are trying to do some something, they get this.",
            "Which is I'll show you a video in a moment, and these are usually very drug resistant, is myoclonic seizures.",
            "Then the patients have also epileptic seizures, like big tonic clonic seizures, but they are usually pretty well controlled in many patients and most patients by by anti epileptic drugs.",
            "And then they show progressive neurological decline, especially a taxi and regarding cognitive decline, the patients can be categorized into two groups in some forms of PMS there is very significant and rapid cognitive decline and.",
            "Early death of the patients, whereas in others the cognition is pretty what preserved.",
            "So the most severe symptoms, this very severe myoclonus that the patients have so many diseases and mostly they are autosomal recessive Lee inherited and the diagnosis of diseases is challenging because they are rare and they have overlapping clinical features.",
            "And like I said the prognosis is in most cases very poor and there is no cure at the moment.",
            "Anne."
        ],
        [
            "I show here.",
            "A video of a finished patients with the most common form of PME, which is called APM.",
            "One or 131 bug disease and this shows quite nicely there.",
            "The clinical features so the patients develop normally until about 6 to 18 years of age, which is the age of onset.",
            "Then they start to get this action activated Mayo Clonus which is progressive and then there's stimulus sensitivity.",
            "For example the patient is having dark classes becaused stimuli through the I.",
            "Worsening the Mayo clonus.",
            "This particular diseases is belonging to the group where there is no major cognitive decline, but as you can see from the patient, so because of the Maya canuso them everyday tasks are very difficult, and yet the cognition is normal that if we would be able to develop some new treatment for the disease, so the patients would have much improved quality of life because their brain is otherwise working normally.",
            "We know that there is a wide variety in the clinical presentation of the disease, and then there's a long list of different trucks that are used mostly in combination in order to trying to treat the Mayo clonus, which is not treated.",
            "So despite of all the medication that they get, they still have this very severe Mayo clonus and the underlying gene is called Steven B because it was originally described in this Institute.",
            "I think the person responsible for that that finding is sitting there with the door can and then also it was described in Finland.",
            "I think approximately the same time, but at the other name of the of the protein and the genus Cystatin B."
        ],
        [
            "So some words about the evolution of gene identification before the human Genome Project.",
            "We did something that was called functional cloning.",
            "So you need needed to have knowledge on the biochemical basis of the disease in order to find the corresponding gene and the famous examples on these diseases are factor 8 in hemophilia A or Bah gene in phenylketonuria and among PM is the GBA gene.",
            "Incautious disease was.",
            "Identified by these functional means, but then from 1990 onwards, about 20 years we lived the era of positional cloning or positional gene identification, and that meant that you usually needed to have very many families with the recessively inherited disease or one big decree for dominantly inherited disease.",
            "And then you did linkage analysis to to find the chromosomal locus and then in the early days you did a lot of physical mapping and you had to clone the genes in the in the tube.",
            "But whereas in towards the end of of this.",
            "You could also go into the database and look for for jeans in that region from the computer.",
            "But during that year major forms, clinical forms of PME found their jeans, but they also we identified many rare clinical PME forms.",
            "But then from 2010 onwards we have lived the era of next generation sequencing or massive parallel sequencing where we can in one experiment quite cheaply and quite.",
            "Rapidly nowadays read through the whole exome protein coding regions of the genome or even the whole genome.",
            "Increasingly nowadays to look for the mutated gene in a patient.",
            "And it's possible, even in single patients or single families, to be able to find a gene nowadays and by these methods we have identified.",
            "Now they're very rare PME forms PMS without typical presentation, but then also novel common if you can say that the rare disease can be common forms of PME that.",
            "Couldn't be it.",
            "Identified by linkage, and I'll come back to that."
        ],
        [
            "A little bit later now I'll show you a couple of slides with some lists, and in the first slide you have the 2:00 PM images.",
            "The jeans that have gotten EPM, one epilepsy, progressive myoclonic designation in the online Mendelian inheritance of men database.",
            "I there are 10 jeans and Anna 9 diseases Anan.",
            "I have marked the first one with dark zone for it.",
            "Loan book disease caused by Steven or Cystatin B mutations and and I'll talk about that much more.",
            "In my talk we don't go into details of the different genes, this is just showing that there are many genes."
        ],
        [
            "And there are also the group of neurosteroid libraries kenosis that are the most common group of neurodegenerative disorders in children that belong to the PME, and we know many different genes for those disorders as well, and I know that there are interest in these jeans as well in this this House."
        ],
        [
            "And then there are a growing list of other other genes that have been associated with PMS syndrome.",
            "So we have learned much about the molecular genetic basis of PMS.",
            "How?"
        ],
        [
            "But there are still many patients who don't have diagnosis and molecular diagnosis, and this shows a chart by pie chart from the study carried out by Italians.",
            "They have a nationwide study of PME patients and they were able to show that.",
            "38% are due to mutations in cystatin B EPM one disease, and then the next common causes EPM.",
            "2A or B.",
            "The Lafora disease and then the neurosteroid.",
            "Libros kenosis with 6%.",
            "And then then the other much more rare among the PMS.",
            "So there was, there was still.",
            "A group of about 30% of patients who didn't have a genetic diagnosis."
        ],
        [
            "So as I had been studying, PM me or molecular genetics of PM me for many years as had also some burger week in Melbourne so we decided some years ago to combine our patient cohort of unknown cases.",
            "So we had 84 unrelated PME patients without a genetic diagnosis we knew that they were all negative for mutations insisted in B and we we decided that we will carry out carry out a whole exome sequencing study.",
            "Of these 84 patients.",
            "And most of the patients were sporadic, which means that there was only one patient in the family.",
            "But then we had some who had siblings or or children or parent affected with the same disease.",
            "And we carried out the sequencing Sanger Institute in the United."
        ],
        [
            "Kingdom and this shows how we did analyze the data.",
            "So we had the exomes of all these patients and they had almost 40,000 a variance per patient.",
            "So we did a lot of bioinformatics and filtering for potentially damage in coding variants in this consensus coding sequences and then analyze the remaining.",
            "Variants using both model for recessive disorders or model for dominant or Nova mutations.",
            "And we looked for mutations or variants in known already known disease genes, but then also for potential novel images on both recessive and dominant dinova models.",
            "And then we did also look for the mitochondrial genome, but we didn't find any any mutations in the mitochondrial genome."
        ],
        [
            "So what did we find?",
            "So we were able to solve 31% of these unsolved cases by doing this.",
            "This whole exome sequencing study.",
            "What was interesting was that 10 out of the 26.",
            "The patients had mutations in non PMG.",
            "So why didn't the diagnosis can become earlier?",
            "That's because many of the patients had a typical phenotype, so the clinicians didn't think about that.",
            "This could be for example sialidosis due to family days limitation because the patients didn't have a typical eye phenotype and many other examples like that.",
            "Then we had for patients who had mutations in genes that had been previously linked to other neurological disorders, but not to PMS.",
            "So the phenotypic spectrum of these genes, which was then enlarge to also be amiss, and then we had one patient who didn't have a PM me.",
            "So it was a misdiagnosis.",
            "But what was?",
            "We had two surprises.",
            "One surprise was that the majority of the patients in which we found a causative mutation had a dominantly inherited origin of imitation.",
            "I said in the beginning that in most cases PMS have been considered to be recessively inherited, so now we had many patients with dominantly inherited disease and then the other nice surprise, for my PhD student was that 11 patients had a mutation in.",
            "And Eugene, so I always remember the evening when he wrote me in an email that I think there's something, but I'm not totally sure.",
            "But when I read it, I knew that."
        ],
        [
            "He had found something else at something you interesting.",
            "An interesting thing is that the two surprises were combined in this nugene becausw we found in these 11 patients the exactly same missense mutation affecting the arginine 320 in a gene that I in the KC and see one gene and and it was.",
            "Recurrent de Novo mutation.",
            "That means meant that in most parents didn't have the mutation, but it occurred always in the in the in the patient only.",
            "And this case, ENC 1 Gene had not previously been associated with human disease.",
            "But it was known that it was a encoding a subunit of this K V3 sub family of voltage gated potassium channels and and then it was known that another member of this family of potassium channel subunit was was mutated.",
            "In this case, CNC three was mutated in patients with spinocerebellar ataxia.",
            "Quite something was already known about the protein.",
            "It was known that it was mainly expressed in neurons that fire so called high frequency action potential potential zan at this, typically inhibitory Copa ergic interneurons in the neocortex hippocampus and also cerebellar granule neurons."
        ],
        [
            "And this just shows the cartoon of the of the of the channel.",
            "So the mutation occurs in the voltage sensing domain of the potassium channel.",
            "And this red plus where denotes the mutated amino acid.",
            "And interesting, it was only this one that was associated associated with this disease, and we also see Quest.",
            "Many other patients with PM me, but we didn't find any other mutations except for for this one.",
            "I mean as it.",
            "Change recurrently in these patients and then here is just showing that it's very highly conserved.",
            "Arginine that that was affected.",
            "And here is the human Casey NC 3 gene, where in the red highlighted there I mean assets that had been reported to be mutated in in these patients with spinal cerebellar ataxia."
        ],
        [
            "We did also some in vitro electrophysiological studies in Anne Frank Oversuit San found that when we first expressed the mutant channel alone, it didn't produce any potassium channel, as exemplified here, but when."
        ],
        [
            "When we Co expressed it with the wild type channel, we saw that there was a significant reduction in the potassium currents, denoting that there's a dominant negative loss of function effect of on the potassium channel function.",
            "Due to this mutation there was also a slight gain of function effect, so in that the wild type and mutant expressed together activated channel in the more negative voltages.",
            "But this was considered minor.",
            "To the significant loss of function effect of the of the potassium channel.",
            "So it seems that this mutation of this one arginine leads to significant reduction of of channel function in the."
        ],
        [
            "Patients giving further evidence that it's it's really a mutation in these patients.",
            "At this defines her new syndrome, which we call Meek my Concepcion, a tacky ataxia due to potassium channel mutation.",
            "And then we know now 20 cases and this just shows the families how they look like.",
            "In most cases the parents don't have imitation, but the patient has.",
            "But then we had two families in which there was a mutation was inherited from the mother to child Boy Child here.",
            "But then here none of the parents had.",
            "The mutation yet two kids were affected in noting that there must be so called Germline Messiah system in one of the parents.",
            "So even if they don't have in their blood the mutation they must have it in their germline."
        ],
        [
            "So what was interesting for us was that the meek has a very clean, similar clinical presentation of unfair it Luneburg disease, which is the most common form of of PM me.",
            "And this just shows their sort of the comparison of the main features so that the onset age of onset is pretty much the same.",
            "And then the features clinical features are pretty much the same.",
            "And then we were starting to think that how can it be that too?",
            "So sort of from the molecular genetics.",
            "POV very different diseases can have such a such a similar clinical presentation, so one is an dominantly inherited ion channel mutation and the other one is an auto summer recessively inherited mutation in a protease inhibitor, but I'll come back to that a little bit later in my talk."
        ],
        [
            "So then I was able to add a new gene in this list of of PME genes."
        ],
        [
            "Precision medicine patients are waiting for four for treatment for the disorder so.",
            "Now that we have a channel that is mutated in PMA, could there be potential for therapy that could be somehow returned?",
            "Non functional channel function in these patients?",
            "And actually when we were writing the.",
            "The paper, so we became aware of drug company in UK that has had recently developped compounds that are activating this KV-3 channels and they were also already in first clinical trials.",
            "But the indications for everywhere for schizophrenia and tinnitus.",
            "But we have been contacting or they also contacted us then contacted us and after the after the publication came out and now these compounds are being tested in cellular and also animal models that are being developed.",
            "For this disorder, and now that since we know all the patients an and then when new patients come diagnosed with disease, so we have a database where we have all the clinical information from the patient.",
            "So it will be quite easy.",
            "Then once there would be a promising compound then to test it in human patients.",
            "So that would be maybe at least to start with an easy way of going to new treatments."
        ],
        [
            "So how did our external study change the scene?",
            "So the piece of pie of unknown costs became a little bit smaller in that we found the KC and one gene and then with these new associations to without typical phenotypes.",
            "And then you associations too.",
            "Other.",
            "Disease known already known disease genes and we are continuing his study.",
            "We are now doing and second phase and this time we're doing 3 or design, which means that instead of just sequencing the patient DNA, we are trying to get also the parents.",
            "So we have got the parents DNA because we think that maybe there is more jeans with the dominant or even then over dominant mutations that can cause PM me.",
            "But that's still.",
            "On going work."
        ],
        [
            "Then this is a slide I took away.",
            "But then when we discussed in the morning, I took backs.",
            "Some somebody asked how do we diagnose the patients?",
            "Of course the challenges the heterogeneity an that we have many genes and it's difficult for the clinician to decide which gene to study.",
            "But now of course we have the sequencing panels so that there are parallels in which you have many PMA jeans as you can in one experiment study many merchants.",
            "But the problem with those is not all of them are covered in available panels, and then you pay me.",
            "Jeans are identified all the time, so so that they don't really up-to-date the panels.",
            "But what is maybe most challenging is that the mutation that is most common in PME patients, their expansion, mutation in the cystatin BG cannot be detected in current panels, so that in principle all the PME patients should first be screened for system.",
            "Be mutations and then if nothing is found they should be then sequenced with panels and this just shows how we do the analysis.",
            "In Hellsing, Alisa, this is a patient who is who has at least order, repeat expansion and then this carrier, parents, parents.",
            "So it's quite easy.",
            "With PCR, even if it's a bit challenging because it's only Jason sees, but we don't come back baby."
        ],
        [
            "We don't talk about that, but then of course we have other mutations.",
            "For example the MIC mutation, this one single mutation is quite easy to screen, also rapidly in the patient with the phenotype that is compatible and then we have also other other.",
            "Founder mutations that can be sick sequence, but I think the whole exam sequencing is coming more and more.",
            "Also to the clinical diagnosis instead of choosing apparel or choosing 1 gene, you can do the whole exome and maybe in the future.",
            "Also the whole genome to do the diagnosis.",
            "But there are still challenges in especially with the genome that you find very many mutations or variants and then two.",
            "Then choose which one is the right one so it's not not totally easy.",
            "Easy do it."
        ],
        [
            "That way well then I'm changing gears to EPM one, and then I already mentioned the cystatin B gene many times and limitations, so the primary defect is loss of function mutations assisted in bijian in most cases in Finland, 98% of the patients are Homo cycles.",
            "For this expansion of there's three.",
            "To three in normal population of these dodeca Meyer 12 nucleotide repeat.",
            "But then in patients who have at least 30 copies of that repeat.",
            "And that's in the promoter region of Cystatin B, resulting in reduced expression of the Cystatin BG and gene and protein.",
            "And then there are 16 other mutations that have been reported that they affect.",
            "The transcript of Cystatin B. Hi there is some variability in the patients phenotype when they have a homozygous expansion mutation.",
            "But what is interesting is that there are patients who have on one allele from one parent inherited the dodeca very expensive mutation but then they have a stop mutation in the other alley.",
            "We have those patients in Finland quite a few and they have a more severe phenotype.",
            "They have an earlier age of onset, more severe myoclonus and more severe dystonic seizures and.",
            "Then also their cognition is is more severe and it's still unclear why this is been discussed.",
            "Whether there could be an.",
            "Knows this.",
            "They form fibrils within the cell and it's toxic for the cell, but then also we have the hypothesis that we have is that there may be the mutant protein is degraded and we have also evidence supporting that that when you express the mutant protein, it's only can be expressed only in circumstances where you.",
            "Event protein degradation."
        ],
        [
            "But what is very interesting now from from the point of view of the whole EPM, one story is that they have been now within the 1 1/2 years.",
            "Two publications come out where they have in both applications.",
            "There was a family, whether they had patients who had not the dodeca merit prepared expansion at all.",
            "But they were Homer cycles.",
            "For either this arginine 68 stop mutation or then another frameshift mutation that is predicted to also be may be unstable as soon as an RNA molecule as a protein.",
            "And these patients didn't have EPM.",
            "One they had a much more severe disease, so they had something that was already evident from right after the birth, and it was a progressive microcephaly, and the severe developmental delay.",
            "And and and none.",
            "Neither of these publications did any molecule study or biochemical studies, but they were discussing that.",
            "Maybe these patients don't have at all just that in B in their in their cells, and that's why the patients are more.",
            "Severely affected, whereas EPL one patients, especially the ones that have assisted in BDO, recommend repeat mutation.",
            "They still have some cystatin B left that you survive when you have some cystatin B left, but then if you don't have any then you have a very severe phenotype."
        ],
        [
            "Cystatin B or Stephen B.",
            "It's a very small protein and its inhibitor of of several system caps is at least to my knowledge, at least of PHL, SK, and F. And it's interesting that it's expressed everywhere in the body, but yet the symptoms at least initially, come only from the central nervous system, but also from other systems, so I come later.",
            "And then we have also looked at the where in the cell it's localized so.",
            "And here is like.",
            "That's if usually in the cytoplasm.",
            "But then there's also this punctate localization which is colocalizes with letters, markers, and then there's also nuclear localization of cystatin B and what is interesting is that patient mutations that are predicted to affect binding with system cat epcis they lose their lysosomal punctate localization, but they are more diffusely localized in the in the cell and then.",
            "They are enriched in the nucleus and here is 1 example of such such mutation and we have studied a few others of those as well that the patient misses.",
            "Mutants failed to associate with lysosomes."
        ],
        [
            "Anne Natasha's group has also reported that when there's inflammatory stimulus, the cystatin B may translocate to mitochondria and also that system in be in the nucleus, interacts with histones, HZH, B&H 3 and then, also with cathepsin L and then and then.",
            "It's known that cathepsin L is involved in cleavage of the cooks.",
            "One transcription factor and.",
            "Their buys accelerate accelerating progression into the S phase of the cell cycle.",
            "Cathepsin L has also been reported to be.",
            "Processing or proteolytically processing.",
            "The end terminal tail of histone three during mouse embryonic stem cell differentiation.",
            "So it's really interesting this this sort of combination of cystatin B nucleus and cathepsin L in the new clothes and what is what is the function of.",
            "Of this of Cystatin B and the new clothes."
        ],
        [
            "And here we just show from human cells that what I already said that this is the patient who is homozygous for their daughter, repeat and has about 10% of the of the.",
            "Expression of cystatin B Arney level and protein level and then.",
            "Here is a patient with with the stop codon mutation that seems to have less than.",
            "Big expression on protein level."
        ],
        [
            "Then of course, if we want to study, study them.",
            "I don't see it here.",
            "Study the disease mechanisms we need.",
            "Model and then Acutal published in 1998.",
            "Mouse model forces that in.",
            "Beware the mice.",
            "The middle one is the affected 1.",
            "Is sleeping and then is having this twitches?",
            "And then is sort of catapulted into the air because of the Mayo clonus?",
            "So it's three capital eights, the myoclonic phenotype in human patients.",
            "In some aspects, it has my Kronos, but in demise it's during the sleep, whereas in human patients when they are active and when they're trying to do something, but they also have a progressive phenotype, they get progressive ataxia that becomes clinically evident at six months of age.",
            "There have been some anecdotal.",
            "Reports from human EPM on patients having benefited from antioxidant therapy, and we therefore wanted to see whether whether."
        ],
        [
            "Statin B at efficiency might be associated with oxidative stress, and I show some data from this, this and all the publication but.",
            "So that we were able to see this is from cerebellar granule cell primary cultures.",
            "We were able to show that in response to oxidative stress.",
            "In the expression is is increased and then also be able to show that.",
            "In these mice, cystatin B deficient mice they are sensitized to oxidative stress including induced cell death.",
            "So they're they die more easily due to oxidative stress and we were able to show by rescue experiments that this was specific for cystatin B.",
            "Fish."
        ],
        [
            "We also studied the Caps in B and we made a hypothesis that may be catching be would be mediating this because there had been also the publications from a double knockout mouse by services that in big SMB whether the apoptosis phenotype in there or cell death, phenotype in the mass was less severe in this double knockout mice and we were also able to show that that cathepsin B is expression is increased in response to oxidative stress and then also the.",
            "Pepsin activity in this cerebellar granule cells is increased in response to oxidative stress and then with R and AI experiments we were able to show this was over expression of cathepsin B increased cell death and RNA I.",
            "Based cell death in response to oxidative stress.",
            "And then importantly, we were able to show that cathepsin BR and I was able to counteract the increased sensitivity to oxidative stress into induced cell death caused by cystatin B deficiency."
        ],
        [
            "We were also interested whether oxidative stress could incur oxidative damage in the in the in vivo in this patients mice and we did a Red X analysis when unable to find that the mice had decreased, so activity and also reduced levels of glutathione in and then increased oxidized to reduce glutathione in levels, implying that there is impaired oxygen oxidative.",
            "Capacity in these cells.",
            "And it's well known that oxidative stress and these free radicals can cause problems too.",
            "Or damage DNA proteins or lipids.",
            "And we also did study this one, but we didn't show any damage of DNA only or protest.",
            "But we we saw in.",
            "Increased lipid damage to lipids in mice at six months of age and this was progressive from two months onwards.",
            "This an it was mainly in the only in the cerebellum, not in other parts of the brain regions.",
            "And then they also had increased levels of this glutathione peroxidase activity, which is most likely an adaptive process to do this increased lipid damage.",
            "So together these studies imply that.",
            "Just then be deficiency increases cerebella susceptibility to oxidative damage and this is impaired by reflected by impaired oxidative capacity and compromised lipid integrity."
        ],
        [
            "Then about the pathology in the in the mice.",
            "So I already told that the mice have.",
            "Myoclonus at one month of age and a taxi at six months of age and what is."
        ],
        [
            "Interesting is that the earliest neuropathological finding that we see is that there is a microglia gliosis that becomes evidence already at P14.",
            "And you can see here that P14 microglial have an activated phenotype at and what month they look very angry looking phagocytosis, microglia and then we have seen."
        ],
        [
            "That as the Gliosis follows at about one month of age and then from."
        ],
        [
            "One month on words, there is a progressive neuron loss."
        ],
        [
            "And then we have done also DT MRI imaging in the brains of these mice and have been able to show the blue color implies white matter damage in the my.",
            "So they have also white matter damage as."
        ],
        [
            "Patients, and then there is a significant volume loss, especially in the cerebellum.",
            "So you can see that compared to the wild type at six months, the cerebellum is is severely diminished in size and in some sense this is reflecting the phenotype of the patients that were described in the past year.",
            "They didn't have cystatin B at all, they had a very severe progressive microcephaly, so this is maybe modeling more that disease then.",
            "EPN one disease.",
            "But of course it's modeling system can be deficiency."
        ],
        [
            "So we have been interested in this micro gliosis feed."
        ],
        [
            "Taipan."
        ],
        [
            "And have done in vitro called in Inverted Vista culture at Macro Micro glia some studies and have been able to show that the maglaya expressed a lot of cystatin B compared to neurons and astrocytes, and it's also increased in response to LP S stimulus.",
            "And then we have been able to show that they have altered chemical and release.",
            "They're more chemo, tactically.",
            "Active the mice from their cystatin B knockout microglia and then that there there is no significant in vitro significant decline in phagocytosis.",
            "But maybe if you can say a tendency towards that."
        ],
        [
            "And then we have done also.",
            "Expression studies from the culture at microglia have been able to show that there is impaired signaling.",
            "We interferon pathway."
        ],
        [
            "In collaboration with the group in Spain, Amanda Sierra, who's done a lot of phagocytosis studies we have sent her the samples of these mice and she has been done.",
            "These studies and she has been able to show that the mice already at P14 have increased of ptosis in the hippocampus and then they try to sort of compromise for the increased apoptosis by increasing the number of micro client but not enough in order to be.",
            "Able to clear that there all the web dot Excel so that the phagocytosis in capacity of this Misys impaired.",
            "So clearly there is a problem in the microglial phagocytosis function, which is important for developing neural networks and also sort of refining neural networks postnatally until about teenage years.",
            "By synaptic pruning.",
            "But that's still something that needs to be studied in more detail."
        ],
        [
            "We have characterized also the micro glia directly extracted from brace and have been shown that they are polarized to the proinflammatory phenotype.",
            "They are more more pro inflammatory polarized."
        ],
        [
            "And then that we have been able to show that with.",
            "Various studies that there is increased inflammation in the brain that increased expression of many inflammatory markers that I think in the interest of time I'm not going into the."
        ],
        [
            "The test and then also there's an increased invasion of peripheral T lymphocytes and granulocytes in the brain.",
            "And the Vascularisation is is increased.",
            "But Interestingly, the blood brain barrier seems to be intact or still at P30H.",
            "So there is.",
            "Altered functional properties of microglia.",
            "They react in an abnormal way which is resulting in inflammatory feel."
        ],
        [
            "Type in the brain.",
            "Of course there is a brain phenotype, but then we have asked the question that.",
            "Of course I'll show soon because of of Natasha's work as well.",
            "That would the mice show also peripheral inflammatory features.",
            "An interesting we found from the theorem of these mice that they had very many different site concept where increased in their serum.",
            "This proinflammatory cytokines that Interestingly this sexy L13 seems to be one that was very highly.",
            "Increased an also narne level from the MRI expression.",
            "Studies that we had done previously.",
            "We found a 29 increased expression of the gene for CXC 13 that seems to be sort of the hallmark of the microglial activation in these mice."
        ],
        [
            "Then to work done in this Natasha's group.",
            "So Natasha has been working on her group, has been working on a little bit different background what mouse mouse over than what we have.",
            "But it's interesting that we have, even if the background is different, we have very similar findings in that.",
            "First of all, she has been able to show that there is this.",
            "The mice are more sensitive to LP's induced in the toxemia as shown shown here.",
            "And then."
        ],
        [
            "Also, that MPs which is applying for LTC stimulus increases the pro inflammatory cytokines.",
            "Instead, almost cystatin B mice and what's interesting is that when we didn't use any LP's induction in our minds, we were not able to see increased levels of Interleukin 1 beta so but but it was shown here so that you need an inflammatory stimulus in order to increase that.",
            "Situation of interlocking one beat them."
        ],
        [
            "And finally.",
            "From these peripheral or bone marrow derived macrophages that's been shown that there is altered inflammasome and interleukin 1 beta pathway activation in cystatin B.",
            "My so that is shown by increased caspase 11 and caspase 10 expression and also increased processing of interleukin 1 beta.",
            "So All in all there's clear signs that there is information."
        ],
        [
            "That is playing role in the pathogenesis of EPM, one disease, and we have asked, well, is it a neurological disease, or is it an auto inflammatory disease?",
            "And of course, this is something that we are not.",
            "We don't have an answer yet too, but things are not as easy.",
            "It's not only information, actually."
        ],
        [
            "When I said that the earliest butter logical change, so neuropathological change that we saw was in P. 14 miles, but we have done also some electrophysiological studies from.",
            "Arabella of P5 Post Natal Day five mice and studied the electrophysiological properties of perky sales.",
            "And I'm not going into the details, but summarizing these findings is that already at P4, the cystatin B mice show alterations in this Cup magic signaling.",
            "And they don't have.",
            "Problems in the numbers of neurons interneurons at that time?",
            "Yet, but they seem to have problems in the synaptic synapses or couple logic terminals, diminished, diminished in numbers.",
            "And also there's reduced, like unbinding of Cafe receptors, implying that there might be a problem of this couple.",
            "Jack inhibitory networks already early.",
            "Early in the disease."
        ],
        [
            "About the Genesis and this is our sort of current hypothesis, so we have, on the other hand micro glia neurons.",
            "We also have astrocytes, but this we have not yet touched so."
        ],
        [
            "So the idea?"
        ],
        [
            "Is that?"
        ],
        [
            "We know that if cystatin beasts reduced in expression in microglia, you have altered functional properties and the increased secretion of inflammatory mediators and then, on the other hand it can result in altered neural excitability."
        ],
        [
            "And then there is the vicious."
        ],
        [
            "Cycle that this altered neural network excitability leads to activation of micro."
        ],
        [
            "Why and then increased expression of?"
        ],
        [
            "Probably inflammatory stimulators, neural damage there."
        ],
        [
            "And then more secretion of inflammatory triggers and."
        ],
        [
            "And it's it's this vicious cycle that keeps on going.",
            "And if we would somehow could interfere with this one, that might be to the benefit of."
        ],
        [
            "Nations, then there's some words about the unifying pathological mechanisms that I promised to tell you in earlier in my talk.",
            "So EPM one, and make the two diseases with different genetic basis, and then the primary defect, and then very similar.",
            "The clinical and your physiological features.",
            "So the unifying theme here is the Cup allergic networks or kojic interneurons and problems in those.",
            "So so good, could this be the joint pathological mechanisms that the Copa ERGIC inhibition early on is his is impaired in in these diseases?"
        ],
        [
            "So of course, patients hope for.",
            "New medications and it's important that we work towards direction.",
            "Although it's very important also to understand all the details and but I think at least the finished funders want that.",
            "We do translation of these research and we want to find new treatments.",
            "And of course should we try to focus on modulating specific neuro physiological system.",
            "Of course I think it's more interesting, at least at this point is to direct the therapist to molecular lesions.",
            "An for example I in general.",
            "I can make and then also the modulation and inflammation and oxidative stress because if you be good.",
            "Based on our hypothesis, diminish this oxidative stress information and then thereby affecting the neural excitability and then that would be.",
            "Benefit beneficial for the patients, but then of course the timing of the treatment if the damage is done already very early or during the post Natal development, then we should be able to try to.",
            "To attack the problem earlier and not in the symptomatic patients first.",
            "Then of course, if we can also focus on downstream."
        ],
        [
            "Targets so very.",
            "Quickly some conclusions.",
            "I think I have convinced you that PMS is a clinically and genetically very heterogeneous group of diseases, and that's.",
            "We can nowadays diagnose it in most cases and that we have tools in our hands that we can also maybe complete the molecular genetic spectrum of of PMS in the near years.",
            "And that all has helped patients.",
            "But of course we now need to focus on on translation at robotic approaches, which is not easy, for example, as exemplified in EPM, one that is a complex interplay with numerous Anglian affect in neural survival and involved in oxidative stress and inflammation.",
            "So there's still much work to be done and I hope to be able to find something to help for the patients before I retire."
        ],
        [
            "And this is then acknowledgements my my my current group and my current collaborators and and the funding.",
            "So thank you for your attention.",
            "Thank you very much.",
            "This was a very nice talk, so the paper is open for questions.",
            "Thank you for excellent presentation, Angelina.",
            "What I'm interesting is you mention patient that have that are homogeneous for Argentine 68 mutations.",
            "Do they have more pro inflammatory phenotype that they have high inflammation?",
            "Whether it's not known yet because they were they were published like as a clinical report.",
            "So within the year.",
            "So I think I should contact them and maybe ask for.",
            "Fibroblast cell lines and we could do this.",
            "I PS cells and then to have them because we have IPS cells from human EP and one patient, so it would be nice to have their Mesa to compare the different phenotypes including the inflammatory here.",
            "But nothing is known about that yet.",
            "Since you mentioned that they have problems with violation it.",
            "Is it possible that is like in autoimmune diseases when you have destruction of myelin?",
            "Yes, that's one possibility, but of course we don't know that we have been thinking because of course we saw so significant myelin loss in APL one.",
            "Nations and then also the mouse with the parallel study.",
            "So I've been thinking that it would be secondary to general death, so the nurse died so you don't need a white matter and it's it's it's cleared away.",
            "But of course there is a possibility that there is also a development aspect there as well that it could be effective.",
            "Hello hi, thank you for talk.",
            "I have a question regarding the stop code on arginine and though the Camaro repeat you mentioned that in Finland.",
            "Have patience with both mutations and they have severe problems.",
            "However you also find in one case that only has stop codon mutation and that was the most severe form or basically lacking Steven B.",
            "So what is the linkage here?",
            "Because in the first case you have both mutations and it's not such a severe case.",
            "As compared to that one.",
            "OK, so maybe I wasn't clear enough in them in the.",
            "In the case where you have.",
            "2 copies of the Dodeca Mary repeat expansion.",
            "You have maybe 10% of cystatin B expression left in your cells.",
            "Then when you have one copy from one parent of the system in BDO decametric suppression expansion mutation, and then the stop codon mutation, how my hypothesis?",
            "An hour data point to it that in that from that allele you don't get functional cystatin B at all, so that their level of cystatin B might only be 5% or even less, and then these patients that were published where they didn't have the expansion mutation at all, but they have only two.",
            "2 copies or from both parents, the stop mutation.",
            "They might not have any sister didn't be so that it would be like a threshold effort, but if you have some cystatin B, you get EPM one you have half of the sum.",
            "You get more severe pain, one if you don't have any, you get another disease.",
            "Well, to your explanation I would have the suggestion that if you do have an opportunity to have patients cells that you do try if there might be this gaining toxic function due to let's say aggregation of this protein when it is mutated.",
            "But my question one is for the therapy, is it possible to change the gene?",
            "Is that close to the clinic well?",
            "Well.",
            "In principle, I mean there are new methods coming all the time, so that would be also maybe the possibility that you have now this crisp.",
            "I've kissed by glass technology that you could.",
            "You might be able to delete the expansion mutation and have normal expression of cystatin B and that obviously is something that should be pursued.",
            "You should only have a whole army of people working on the money of the whole Finnish government to do this, and that would be obviously a very interesting.",
            "Excellent presentation it since you saw also.",
            "Operations in motor function.",
            "Did you saw any correlation with Parkinson's disease?",
            "Do you mean?",
            "Phenotypes that would be exactly because actually, I mean you you found also in Eugene, which shows also very similar phenotype to EPM wise, but now, maybe not not so much to Parkinson's disease, but but what has been discussed in EPM one is because it's usually, I mean, it's progressing microns epilepsy, because they have epilepsy.",
            "As one of the vino ties.",
            "But then the myoclonus is the most severe presentation, and so it's been also discussed that whether it's an epileptic phenotype because in many cases, when you have Mayo clonus, you can see the EG.",
            "That there is a corresponding e.g.",
            "Change that so that it would be an epileptic myoclonic between many patients.",
            "You don't see they can have a very severe myoclonic sort of attack and then you take each.",
            "You don't see anything and that implies that you get the Maya clones from deeper structures.",
            "That would be more like maybe Parkinson like, but more like a movement disorder.",
            "They're like, yeah yeah.",
            "But if you see, for example, I mean, you see the patient instability.",
            "When you see the tremors which add features which are pretty much in common with Parkinson's disease, yes, I'm not a clinician seeing myself, but I know that there is in the old literature.",
            "It's always says that there's some trim or also, but I think it's.",
            "The parents describe at least tremor, but it's a tremor.",
            "Is it?",
            "Mayo clonus?",
            "Or is it a taxi?",
            "It's very hard.",
            "Then you need to really help, but I had to my understanding the patients they have this myoclonus that they have like a drop off of muscle tone suddenly and then they can have this a taxi.",
            "That they cannot really, but that could be also partially due to to to my clonus, but the three more they don't really have, at least to my understanding, thank you.",
            "Other more questions.",
            "Concerning genetic diseases, I think we're still far away, especially gene replacement or whatever.",
            "This is we are far away, but I think what's maybe more important people are concentrated when they discover one.",
            "This is their constant.",
            "It usually on one June, and what I think what is the future indeed to study much more deeply and other possibilities then?",
            "Because there is some, I believe some cooperation between all this.",
            "Genes and resulting proteins, of course.",
            "And this my opinion might be.",
            "Direction to the future.",
            "We mean modifying genes, genes modifying the phenotype.",
            "Yeah yeah, that's that's true.",
            "And this is this is certainly something that should be.",
            "We have also been thinking about that.",
            "How should we do the problem?",
            "Maybe with the rare diseases that they are rare and then most likely you will have many modifying genes.",
            "So how would you have the statistical power to choose them?",
            "But of course you could make some educated guesses about.",
            "For example, the inflammatory phenotype, would you be able to like?",
            "Study some candidate genes as modifying genes so, but this is certainly something that we need to work on.",
            "For example, in EPM, one within the family, you can have a patient who is wheelchair bound and the patient who is walking so that they.",
            "They have the same mutation that they have a very similar genetic background, but yet they have something that is different because their phenotype is very different and also in the mouse.",
            "But I said that we are working with a different mouse background with Natasha, so we're working with this.",
            "We 129 that has the Mayo Clinic, Savannah type at one month and then there is the early inflammatory phenotype.",
            "But when we put the mutation into C 57 black background, we don't get Mayo clonus at least by four months of age.",
            "We didn't look any further than that.",
            "And that was also published by Pennacchio Tell and also the the.",
            "If my microglial inflammation phenotype cause much more late and it's much less, it's less severe.",
            "So that's one thing that we have been thinking that maybe we should.",
            "With the mice we should try to map what is the.",
            "What are the jeans that in or the jeans that make this difference?",
            "Mouses mouse, but yet they have a very different and they have.",
            "They have an inbred congenic background, so that might be one way of.",
            "Going further.",
            "Anymore questions.",
            "I have the last question or another question from the general public, that's me.",
            "So what is speech in this PME patients like?",
            "So what is speech?",
            "How do they?",
            "How do they talk?",
            "It's they have dysarthria.",
            "It's sometimes when I have I give talks to them and then they ask me questions.",
            "Sometimes it's very hard to.",
            "To understand because they also have this Mayo clonus in their mouth.",
            "So it's very hard to understand their speech many times if they have like you said, it happens, the seizures happen or the tremor happens when somebody wants to do something and speech is usually voluntary.",
            "So yes, speeches is one thing.",
            "It's they have.",
            "It's very hard to.",
            "Understand when many times what they're asking, especially if they're a little bit stressed about asking, then it becomes women were movers.",
            "OK, thank you very much.",
            "Thank you."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Good afternoon, I think it shows that this is the first colloquium out there.",
                    "label": 0
                },
                {
                    "sent": "The new the academic year, the new season, the first speaker is professor on Eileena Legacy.",
                    "label": 0
                },
                {
                    "sent": "Okie, from from Finland she got her MD.",
                    "label": 0
                },
                {
                    "sent": "From the University of Helsinki in 85 and then she got a PhD in medicine from the University of Helsinki in 89 and then a PhD in medical molecular genetics, also from the University of Helsinki in 97.",
                    "label": 0
                },
                {
                    "sent": "She held many positions from being a research fellow and then a research associate at the University of Helsinki.",
                    "label": 0
                },
                {
                    "sent": "Then the scientists would be Academy of Finland.",
                    "label": 0
                },
                {
                    "sent": "Then she was a visiting research associate at the University of California at San Francisco.",
                    "label": 0
                },
                {
                    "sent": "Then a senior fellow at University of Helsinki and so on.",
                    "label": 0
                },
                {
                    "sent": "The list is pretty long, but currently she is research director and professor at the Neuroscience Center at the University of Helsinki since 2003, and then since 2004 and six she's head of Focus on Institute of Genetics and Research Center, respectively.",
                    "label": 1
                },
                {
                    "sent": "And since 2013, she's group leader at the Molecular Neurology Research Program, Faculty of Medicine, University of Helsinki, Domain research topics.",
                    "label": 0
                },
                {
                    "sent": "Of Professor Li, his Yorkie revolve around the understanding of molecular basis of epilepsy syndromes through identification of underlying defective genes followed by functional analysis of gene products and characterization of disease mechanisms in cellular and animal models, and today she is going to tell us about her recent and perhaps some more established results.",
                    "label": 0
                },
                {
                    "sent": "Thank you very much for the introduction and thank you Natasha for inviting me and it's allowing me to visit for the first time.",
                    "label": 0
                },
                {
                    "sent": "The beautiful city of Ljubljana so has pretty much already told me I have a background in human molecular genetics alot and I have been happy to witness the revolution in the Human Genetics research during the past two decades thanks to the Human Genome Project.",
                    "label": 0
                },
                {
                    "sent": "So the progress has been enormous and we have witnessed.",
                    "label": 0
                },
                {
                    "sent": "A significant progress in understanding the genetic basis of human inherited diseases, especially in rare diseases.",
                    "label": 0
                },
                {
                    "sent": "My own interest has been in in epilepsy syndromes, especially in different form of forms of progress in microns, epilepsies, and of course, when we're doing molecular genetics research, we have always the patient behind, so we want to find a diagnosis by finding a gene and then from gene going forward to understand function of the gene product mechanisms of the disease, and then then in the end.",
                    "label": 0
                },
                {
                    "sent": "Two to produce new treatments for the patients because they are really expecting it so.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Today I'm going to talk about progressive microns epilepsies, with the question of we on the way to precision medicine, and I have outlined my talk so that I will first define what is progressive myoclonus epilepsy, and then I showed the tell you about the evolution of how understanding of molecular genetics of PPMS or burgers in my Kronos epilepsies hackerd, and then I will tell you about our recent molecular genetics work that resulted in identification of the new PMS syndrome.",
                    "label": 1
                },
                {
                    "sent": "And then quite a lot of time of my reaches I will tell about.",
                    "label": 0
                },
                {
                    "sent": "One specific PME and that has been a major interest of my research for many years and also interest in this Institute.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So progressive myoclonic epilepsy is they are group of diseases.",
                    "label": 1
                },
                {
                    "sent": "Rare genetic epilepsies.",
                    "label": 0
                },
                {
                    "sent": "They are rare.",
                    "label": 0
                },
                {
                    "sent": "The overall prevalence is approximately one in ten 100,000 individuals, but we are.",
                    "label": 0
                },
                {
                    "sent": "We have a variation due to founder effects.",
                    "label": 1
                },
                {
                    "sent": "For example, in Finland we have a peculiar population history, and in Finland we have a prevalence of one in 25,000 individuals of PMS.",
                    "label": 1
                },
                {
                    "sent": "So it's a heterogeneous group.",
                    "label": 0
                },
                {
                    "sent": "Many causes many different prognosis, different clinical manifestations, and also different costs.",
                    "label": 0
                },
                {
                    "sent": "But they all patients share a triad of symptoms.",
                    "label": 0
                },
                {
                    "sent": "They all have this myoclonic seizures, which are involuntary twitches of muscles, and especially something that is called action myoclonus, which means that when they are trying to do some something, they get this.",
                    "label": 0
                },
                {
                    "sent": "Which is I'll show you a video in a moment, and these are usually very drug resistant, is myoclonic seizures.",
                    "label": 0
                },
                {
                    "sent": "Then the patients have also epileptic seizures, like big tonic clonic seizures, but they are usually pretty well controlled in many patients and most patients by by anti epileptic drugs.",
                    "label": 0
                },
                {
                    "sent": "And then they show progressive neurological decline, especially a taxi and regarding cognitive decline, the patients can be categorized into two groups in some forms of PMS there is very significant and rapid cognitive decline and.",
                    "label": 0
                },
                {
                    "sent": "Early death of the patients, whereas in others the cognition is pretty what preserved.",
                    "label": 0
                },
                {
                    "sent": "So the most severe symptoms, this very severe myoclonus that the patients have so many diseases and mostly they are autosomal recessive Lee inherited and the diagnosis of diseases is challenging because they are rare and they have overlapping clinical features.",
                    "label": 0
                },
                {
                    "sent": "And like I said the prognosis is in most cases very poor and there is no cure at the moment.",
                    "label": 0
                },
                {
                    "sent": "Anne.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "I show here.",
                    "label": 0
                },
                {
                    "sent": "A video of a finished patients with the most common form of PME, which is called APM.",
                    "label": 0
                },
                {
                    "sent": "One or 131 bug disease and this shows quite nicely there.",
                    "label": 0
                },
                {
                    "sent": "The clinical features so the patients develop normally until about 6 to 18 years of age, which is the age of onset.",
                    "label": 1
                },
                {
                    "sent": "Then they start to get this action activated Mayo Clonus which is progressive and then there's stimulus sensitivity.",
                    "label": 0
                },
                {
                    "sent": "For example the patient is having dark classes becaused stimuli through the I.",
                    "label": 0
                },
                {
                    "sent": "Worsening the Mayo clonus.",
                    "label": 0
                },
                {
                    "sent": "This particular diseases is belonging to the group where there is no major cognitive decline, but as you can see from the patient, so because of the Maya canuso them everyday tasks are very difficult, and yet the cognition is normal that if we would be able to develop some new treatment for the disease, so the patients would have much improved quality of life because their brain is otherwise working normally.",
                    "label": 1
                },
                {
                    "sent": "We know that there is a wide variety in the clinical presentation of the disease, and then there's a long list of different trucks that are used mostly in combination in order to trying to treat the Mayo clonus, which is not treated.",
                    "label": 0
                },
                {
                    "sent": "So despite of all the medication that they get, they still have this very severe Mayo clonus and the underlying gene is called Steven B because it was originally described in this Institute.",
                    "label": 0
                },
                {
                    "sent": "I think the person responsible for that that finding is sitting there with the door can and then also it was described in Finland.",
                    "label": 0
                },
                {
                    "sent": "I think approximately the same time, but at the other name of the of the protein and the genus Cystatin B.",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So some words about the evolution of gene identification before the human Genome Project.",
                    "label": 1
                },
                {
                    "sent": "We did something that was called functional cloning.",
                    "label": 0
                },
                {
                    "sent": "So you need needed to have knowledge on the biochemical basis of the disease in order to find the corresponding gene and the famous examples on these diseases are factor 8 in hemophilia A or Bah gene in phenylketonuria and among PM is the GBA gene.",
                    "label": 1
                },
                {
                    "sent": "Incautious disease was.",
                    "label": 0
                },
                {
                    "sent": "Identified by these functional means, but then from 1990 onwards, about 20 years we lived the era of positional cloning or positional gene identification, and that meant that you usually needed to have very many families with the recessively inherited disease or one big decree for dominantly inherited disease.",
                    "label": 0
                },
                {
                    "sent": "And then you did linkage analysis to to find the chromosomal locus and then in the early days you did a lot of physical mapping and you had to clone the genes in the in the tube.",
                    "label": 0
                },
                {
                    "sent": "But whereas in towards the end of of this.",
                    "label": 0
                },
                {
                    "sent": "You could also go into the database and look for for jeans in that region from the computer.",
                    "label": 1
                },
                {
                    "sent": "But during that year major forms, clinical forms of PME found their jeans, but they also we identified many rare clinical PME forms.",
                    "label": 0
                },
                {
                    "sent": "But then from 2010 onwards we have lived the era of next generation sequencing or massive parallel sequencing where we can in one experiment quite cheaply and quite.",
                    "label": 1
                },
                {
                    "sent": "Rapidly nowadays read through the whole exome protein coding regions of the genome or even the whole genome.",
                    "label": 1
                },
                {
                    "sent": "Increasingly nowadays to look for the mutated gene in a patient.",
                    "label": 1
                },
                {
                    "sent": "And it's possible, even in single patients or single families, to be able to find a gene nowadays and by these methods we have identified.",
                    "label": 0
                },
                {
                    "sent": "Now they're very rare PME forms PMS without typical presentation, but then also novel common if you can say that the rare disease can be common forms of PME that.",
                    "label": 0
                },
                {
                    "sent": "Couldn't be it.",
                    "label": 0
                },
                {
                    "sent": "Identified by linkage, and I'll come back to that.",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "A little bit later now I'll show you a couple of slides with some lists, and in the first slide you have the 2:00 PM images.",
                    "label": 0
                },
                {
                    "sent": "The jeans that have gotten EPM, one epilepsy, progressive myoclonic designation in the online Mendelian inheritance of men database.",
                    "label": 0
                },
                {
                    "sent": "I there are 10 jeans and Anna 9 diseases Anan.",
                    "label": 0
                },
                {
                    "sent": "I have marked the first one with dark zone for it.",
                    "label": 0
                },
                {
                    "sent": "Loan book disease caused by Steven or Cystatin B mutations and and I'll talk about that much more.",
                    "label": 0
                },
                {
                    "sent": "In my talk we don't go into details of the different genes, this is just showing that there are many genes.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And there are also the group of neurosteroid libraries kenosis that are the most common group of neurodegenerative disorders in children that belong to the PME, and we know many different genes for those disorders as well, and I know that there are interest in these jeans as well in this this House.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then there are a growing list of other other genes that have been associated with PMS syndrome.",
                    "label": 0
                },
                {
                    "sent": "So we have learned much about the molecular genetic basis of PMS.",
                    "label": 0
                },
                {
                    "sent": "How?",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "But there are still many patients who don't have diagnosis and molecular diagnosis, and this shows a chart by pie chart from the study carried out by Italians.",
                    "label": 0
                },
                {
                    "sent": "They have a nationwide study of PME patients and they were able to show that.",
                    "label": 1
                },
                {
                    "sent": "38% are due to mutations in cystatin B EPM one disease, and then the next common causes EPM.",
                    "label": 0
                },
                {
                    "sent": "2A or B.",
                    "label": 0
                },
                {
                    "sent": "The Lafora disease and then the neurosteroid.",
                    "label": 0
                },
                {
                    "sent": "Libros kenosis with 6%.",
                    "label": 0
                },
                {
                    "sent": "And then then the other much more rare among the PMS.",
                    "label": 0
                },
                {
                    "sent": "So there was, there was still.",
                    "label": 0
                },
                {
                    "sent": "A group of about 30% of patients who didn't have a genetic diagnosis.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So as I had been studying, PM me or molecular genetics of PM me for many years as had also some burger week in Melbourne so we decided some years ago to combine our patient cohort of unknown cases.",
                    "label": 0
                },
                {
                    "sent": "So we had 84 unrelated PME patients without a genetic diagnosis we knew that they were all negative for mutations insisted in B and we we decided that we will carry out carry out a whole exome sequencing study.",
                    "label": 1
                },
                {
                    "sent": "Of these 84 patients.",
                    "label": 0
                },
                {
                    "sent": "And most of the patients were sporadic, which means that there was only one patient in the family.",
                    "label": 0
                },
                {
                    "sent": "But then we had some who had siblings or or children or parent affected with the same disease.",
                    "label": 0
                },
                {
                    "sent": "And we carried out the sequencing Sanger Institute in the United.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Kingdom and this shows how we did analyze the data.",
                    "label": 0
                },
                {
                    "sent": "So we had the exomes of all these patients and they had almost 40,000 a variance per patient.",
                    "label": 0
                },
                {
                    "sent": "So we did a lot of bioinformatics and filtering for potentially damage in coding variants in this consensus coding sequences and then analyze the remaining.",
                    "label": 0
                },
                {
                    "sent": "Variants using both model for recessive disorders or model for dominant or Nova mutations.",
                    "label": 0
                },
                {
                    "sent": "And we looked for mutations or variants in known already known disease genes, but then also for potential novel images on both recessive and dominant dinova models.",
                    "label": 0
                },
                {
                    "sent": "And then we did also look for the mitochondrial genome, but we didn't find any any mutations in the mitochondrial genome.",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So what did we find?",
                    "label": 0
                },
                {
                    "sent": "So we were able to solve 31% of these unsolved cases by doing this.",
                    "label": 0
                },
                {
                    "sent": "This whole exome sequencing study.",
                    "label": 0
                },
                {
                    "sent": "What was interesting was that 10 out of the 26.",
                    "label": 0
                },
                {
                    "sent": "The patients had mutations in non PMG.",
                    "label": 1
                },
                {
                    "sent": "So why didn't the diagnosis can become earlier?",
                    "label": 0
                },
                {
                    "sent": "That's because many of the patients had a typical phenotype, so the clinicians didn't think about that.",
                    "label": 0
                },
                {
                    "sent": "This could be for example sialidosis due to family days limitation because the patients didn't have a typical eye phenotype and many other examples like that.",
                    "label": 1
                },
                {
                    "sent": "Then we had for patients who had mutations in genes that had been previously linked to other neurological disorders, but not to PMS.",
                    "label": 0
                },
                {
                    "sent": "So the phenotypic spectrum of these genes, which was then enlarge to also be amiss, and then we had one patient who didn't have a PM me.",
                    "label": 0
                },
                {
                    "sent": "So it was a misdiagnosis.",
                    "label": 0
                },
                {
                    "sent": "But what was?",
                    "label": 0
                },
                {
                    "sent": "We had two surprises.",
                    "label": 0
                },
                {
                    "sent": "One surprise was that the majority of the patients in which we found a causative mutation had a dominantly inherited origin of imitation.",
                    "label": 1
                },
                {
                    "sent": "I said in the beginning that in most cases PMS have been considered to be recessively inherited, so now we had many patients with dominantly inherited disease and then the other nice surprise, for my PhD student was that 11 patients had a mutation in.",
                    "label": 0
                },
                {
                    "sent": "And Eugene, so I always remember the evening when he wrote me in an email that I think there's something, but I'm not totally sure.",
                    "label": 0
                },
                {
                    "sent": "But when I read it, I knew that.",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "He had found something else at something you interesting.",
                    "label": 0
                },
                {
                    "sent": "An interesting thing is that the two surprises were combined in this nugene becausw we found in these 11 patients the exactly same missense mutation affecting the arginine 320 in a gene that I in the KC and see one gene and and it was.",
                    "label": 0
                },
                {
                    "sent": "Recurrent de Novo mutation.",
                    "label": 0
                },
                {
                    "sent": "That means meant that in most parents didn't have the mutation, but it occurred always in the in the in the patient only.",
                    "label": 0
                },
                {
                    "sent": "And this case, ENC 1 Gene had not previously been associated with human disease.",
                    "label": 1
                },
                {
                    "sent": "But it was known that it was a encoding a subunit of this K V3 sub family of voltage gated potassium channels and and then it was known that another member of this family of potassium channel subunit was was mutated.",
                    "label": 0
                },
                {
                    "sent": "In this case, CNC three was mutated in patients with spinocerebellar ataxia.",
                    "label": 0
                },
                {
                    "sent": "Quite something was already known about the protein.",
                    "label": 0
                },
                {
                    "sent": "It was known that it was mainly expressed in neurons that fire so called high frequency action potential potential zan at this, typically inhibitory Copa ergic interneurons in the neocortex hippocampus and also cerebellar granule neurons.",
                    "label": 1
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And this just shows the cartoon of the of the of the channel.",
                    "label": 0
                },
                {
                    "sent": "So the mutation occurs in the voltage sensing domain of the potassium channel.",
                    "label": 0
                },
                {
                    "sent": "And this red plus where denotes the mutated amino acid.",
                    "label": 0
                },
                {
                    "sent": "And interesting, it was only this one that was associated associated with this disease, and we also see Quest.",
                    "label": 0
                },
                {
                    "sent": "Many other patients with PM me, but we didn't find any other mutations except for for this one.",
                    "label": 0
                },
                {
                    "sent": "I mean as it.",
                    "label": 0
                },
                {
                    "sent": "Change recurrently in these patients and then here is just showing that it's very highly conserved.",
                    "label": 0
                },
                {
                    "sent": "Arginine that that was affected.",
                    "label": 0
                },
                {
                    "sent": "And here is the human Casey NC 3 gene, where in the red highlighted there I mean assets that had been reported to be mutated in in these patients with spinal cerebellar ataxia.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We did also some in vitro electrophysiological studies in Anne Frank Oversuit San found that when we first expressed the mutant channel alone, it didn't produce any potassium channel, as exemplified here, but when.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "When we Co expressed it with the wild type channel, we saw that there was a significant reduction in the potassium currents, denoting that there's a dominant negative loss of function effect of on the potassium channel function.",
                    "label": 1
                },
                {
                    "sent": "Due to this mutation there was also a slight gain of function effect, so in that the wild type and mutant expressed together activated channel in the more negative voltages.",
                    "label": 0
                },
                {
                    "sent": "But this was considered minor.",
                    "label": 0
                },
                {
                    "sent": "To the significant loss of function effect of the of the potassium channel.",
                    "label": 0
                },
                {
                    "sent": "So it seems that this mutation of this one arginine leads to significant reduction of of channel function in the.",
                    "label": 0
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Patients giving further evidence that it's it's really a mutation in these patients.",
                    "label": 0
                },
                {
                    "sent": "At this defines her new syndrome, which we call Meek my Concepcion, a tacky ataxia due to potassium channel mutation.",
                    "label": 1
                },
                {
                    "sent": "And then we know now 20 cases and this just shows the families how they look like.",
                    "label": 1
                },
                {
                    "sent": "In most cases the parents don't have imitation, but the patient has.",
                    "label": 0
                },
                {
                    "sent": "But then we had two families in which there was a mutation was inherited from the mother to child Boy Child here.",
                    "label": 0
                },
                {
                    "sent": "But then here none of the parents had.",
                    "label": 0
                },
                {
                    "sent": "The mutation yet two kids were affected in noting that there must be so called Germline Messiah system in one of the parents.",
                    "label": 0
                },
                {
                    "sent": "So even if they don't have in their blood the mutation they must have it in their germline.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "So what was interesting for us was that the meek has a very clean, similar clinical presentation of unfair it Luneburg disease, which is the most common form of of PM me.",
                    "label": 1
                },
                {
                    "sent": "And this just shows their sort of the comparison of the main features so that the onset age of onset is pretty much the same.",
                    "label": 0
                },
                {
                    "sent": "And then the features clinical features are pretty much the same.",
                    "label": 0
                },
                {
                    "sent": "And then we were starting to think that how can it be that too?",
                    "label": 0
                },
                {
                    "sent": "So sort of from the molecular genetics.",
                    "label": 0
                },
                {
                    "sent": "POV very different diseases can have such a such a similar clinical presentation, so one is an dominantly inherited ion channel mutation and the other one is an auto summer recessively inherited mutation in a protease inhibitor, but I'll come back to that a little bit later in my talk.",
                    "label": 1
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So then I was able to add a new gene in this list of of PME genes.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Precision medicine patients are waiting for four for treatment for the disorder so.",
                    "label": 0
                },
                {
                    "sent": "Now that we have a channel that is mutated in PMA, could there be potential for therapy that could be somehow returned?",
                    "label": 0
                },
                {
                    "sent": "Non functional channel function in these patients?",
                    "label": 0
                },
                {
                    "sent": "And actually when we were writing the.",
                    "label": 0
                },
                {
                    "sent": "The paper, so we became aware of drug company in UK that has had recently developped compounds that are activating this KV-3 channels and they were also already in first clinical trials.",
                    "label": 0
                },
                {
                    "sent": "But the indications for everywhere for schizophrenia and tinnitus.",
                    "label": 0
                },
                {
                    "sent": "But we have been contacting or they also contacted us then contacted us and after the after the publication came out and now these compounds are being tested in cellular and also animal models that are being developed.",
                    "label": 1
                },
                {
                    "sent": "For this disorder, and now that since we know all the patients an and then when new patients come diagnosed with disease, so we have a database where we have all the clinical information from the patient.",
                    "label": 0
                },
                {
                    "sent": "So it will be quite easy.",
                    "label": 0
                },
                {
                    "sent": "Then once there would be a promising compound then to test it in human patients.",
                    "label": 0
                },
                {
                    "sent": "So that would be maybe at least to start with an easy way of going to new treatments.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So how did our external study change the scene?",
                    "label": 0
                },
                {
                    "sent": "So the piece of pie of unknown costs became a little bit smaller in that we found the KC and one gene and then with these new associations to without typical phenotypes.",
                    "label": 0
                },
                {
                    "sent": "And then you associations too.",
                    "label": 0
                },
                {
                    "sent": "Other.",
                    "label": 0
                },
                {
                    "sent": "Disease known already known disease genes and we are continuing his study.",
                    "label": 0
                },
                {
                    "sent": "We are now doing and second phase and this time we're doing 3 or design, which means that instead of just sequencing the patient DNA, we are trying to get also the parents.",
                    "label": 0
                },
                {
                    "sent": "So we have got the parents DNA because we think that maybe there is more jeans with the dominant or even then over dominant mutations that can cause PM me.",
                    "label": 0
                },
                {
                    "sent": "But that's still.",
                    "label": 0
                },
                {
                    "sent": "On going work.",
                    "label": 0
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Then this is a slide I took away.",
                    "label": 0
                },
                {
                    "sent": "But then when we discussed in the morning, I took backs.",
                    "label": 0
                },
                {
                    "sent": "Some somebody asked how do we diagnose the patients?",
                    "label": 0
                },
                {
                    "sent": "Of course the challenges the heterogeneity an that we have many genes and it's difficult for the clinician to decide which gene to study.",
                    "label": 0
                },
                {
                    "sent": "But now of course we have the sequencing panels so that there are parallels in which you have many PMA jeans as you can in one experiment study many merchants.",
                    "label": 0
                },
                {
                    "sent": "But the problem with those is not all of them are covered in available panels, and then you pay me.",
                    "label": 1
                },
                {
                    "sent": "Jeans are identified all the time, so so that they don't really up-to-date the panels.",
                    "label": 0
                },
                {
                    "sent": "But what is maybe most challenging is that the mutation that is most common in PME patients, their expansion, mutation in the cystatin BG cannot be detected in current panels, so that in principle all the PME patients should first be screened for system.",
                    "label": 1
                },
                {
                    "sent": "Be mutations and then if nothing is found they should be then sequenced with panels and this just shows how we do the analysis.",
                    "label": 0
                },
                {
                    "sent": "In Hellsing, Alisa, this is a patient who is who has at least order, repeat expansion and then this carrier, parents, parents.",
                    "label": 0
                },
                {
                    "sent": "So it's quite easy.",
                    "label": 0
                },
                {
                    "sent": "With PCR, even if it's a bit challenging because it's only Jason sees, but we don't come back baby.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We don't talk about that, but then of course we have other mutations.",
                    "label": 0
                },
                {
                    "sent": "For example the MIC mutation, this one single mutation is quite easy to screen, also rapidly in the patient with the phenotype that is compatible and then we have also other other.",
                    "label": 0
                },
                {
                    "sent": "Founder mutations that can be sick sequence, but I think the whole exam sequencing is coming more and more.",
                    "label": 0
                },
                {
                    "sent": "Also to the clinical diagnosis instead of choosing apparel or choosing 1 gene, you can do the whole exome and maybe in the future.",
                    "label": 0
                },
                {
                    "sent": "Also the whole genome to do the diagnosis.",
                    "label": 0
                },
                {
                    "sent": "But there are still challenges in especially with the genome that you find very many mutations or variants and then two.",
                    "label": 0
                },
                {
                    "sent": "Then choose which one is the right one so it's not not totally easy.",
                    "label": 0
                },
                {
                    "sent": "Easy do it.",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "That way well then I'm changing gears to EPM one, and then I already mentioned the cystatin B gene many times and limitations, so the primary defect is loss of function mutations assisted in bijian in most cases in Finland, 98% of the patients are Homo cycles.",
                    "label": 0
                },
                {
                    "sent": "For this expansion of there's three.",
                    "label": 0
                },
                {
                    "sent": "To three in normal population of these dodeca Meyer 12 nucleotide repeat.",
                    "label": 0
                },
                {
                    "sent": "But then in patients who have at least 30 copies of that repeat.",
                    "label": 0
                },
                {
                    "sent": "And that's in the promoter region of Cystatin B, resulting in reduced expression of the Cystatin BG and gene and protein.",
                    "label": 0
                },
                {
                    "sent": "And then there are 16 other mutations that have been reported that they affect.",
                    "label": 1
                },
                {
                    "sent": "The transcript of Cystatin B. Hi there is some variability in the patients phenotype when they have a homozygous expansion mutation.",
                    "label": 0
                },
                {
                    "sent": "But what is interesting is that there are patients who have on one allele from one parent inherited the dodeca very expensive mutation but then they have a stop mutation in the other alley.",
                    "label": 0
                },
                {
                    "sent": "We have those patients in Finland quite a few and they have a more severe phenotype.",
                    "label": 1
                },
                {
                    "sent": "They have an earlier age of onset, more severe myoclonus and more severe dystonic seizures and.",
                    "label": 1
                },
                {
                    "sent": "Then also their cognition is is more severe and it's still unclear why this is been discussed.",
                    "label": 0
                },
                {
                    "sent": "Whether there could be an.",
                    "label": 0
                },
                {
                    "sent": "Knows this.",
                    "label": 0
                },
                {
                    "sent": "They form fibrils within the cell and it's toxic for the cell, but then also we have the hypothesis that we have is that there may be the mutant protein is degraded and we have also evidence supporting that that when you express the mutant protein, it's only can be expressed only in circumstances where you.",
                    "label": 0
                },
                {
                    "sent": "Event protein degradation.",
                    "label": 0
                }
            ]
        },
        "clip_24": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "But what is very interesting now from from the point of view of the whole EPM, one story is that they have been now within the 1 1/2 years.",
                    "label": 0
                },
                {
                    "sent": "Two publications come out where they have in both applications.",
                    "label": 0
                },
                {
                    "sent": "There was a family, whether they had patients who had not the dodeca merit prepared expansion at all.",
                    "label": 0
                },
                {
                    "sent": "But they were Homer cycles.",
                    "label": 0
                },
                {
                    "sent": "For either this arginine 68 stop mutation or then another frameshift mutation that is predicted to also be may be unstable as soon as an RNA molecule as a protein.",
                    "label": 0
                },
                {
                    "sent": "And these patients didn't have EPM.",
                    "label": 1
                },
                {
                    "sent": "One they had a much more severe disease, so they had something that was already evident from right after the birth, and it was a progressive microcephaly, and the severe developmental delay.",
                    "label": 1
                },
                {
                    "sent": "And and and none.",
                    "label": 0
                },
                {
                    "sent": "Neither of these publications did any molecule study or biochemical studies, but they were discussing that.",
                    "label": 0
                },
                {
                    "sent": "Maybe these patients don't have at all just that in B in their in their cells, and that's why the patients are more.",
                    "label": 0
                },
                {
                    "sent": "Severely affected, whereas EPL one patients, especially the ones that have assisted in BDO, recommend repeat mutation.",
                    "label": 0
                },
                {
                    "sent": "They still have some cystatin B left that you survive when you have some cystatin B left, but then if you don't have any then you have a very severe phenotype.",
                    "label": 0
                }
            ]
        },
        "clip_25": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Cystatin B or Stephen B.",
                    "label": 1
                },
                {
                    "sent": "It's a very small protein and its inhibitor of of several system caps is at least to my knowledge, at least of PHL, SK, and F. And it's interesting that it's expressed everywhere in the body, but yet the symptoms at least initially, come only from the central nervous system, but also from other systems, so I come later.",
                    "label": 0
                },
                {
                    "sent": "And then we have also looked at the where in the cell it's localized so.",
                    "label": 0
                },
                {
                    "sent": "And here is like.",
                    "label": 0
                },
                {
                    "sent": "That's if usually in the cytoplasm.",
                    "label": 0
                },
                {
                    "sent": "But then there's also this punctate localization which is colocalizes with letters, markers, and then there's also nuclear localization of cystatin B and what is interesting is that patient mutations that are predicted to affect binding with system cat epcis they lose their lysosomal punctate localization, but they are more diffusely localized in the in the cell and then.",
                    "label": 0
                },
                {
                    "sent": "They are enriched in the nucleus and here is 1 example of such such mutation and we have studied a few others of those as well that the patient misses.",
                    "label": 0
                },
                {
                    "sent": "Mutants failed to associate with lysosomes.",
                    "label": 1
                }
            ]
        },
        "clip_26": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Anne Natasha's group has also reported that when there's inflammatory stimulus, the cystatin B may translocate to mitochondria and also that system in be in the nucleus, interacts with histones, HZH, B&H 3 and then, also with cathepsin L and then and then.",
                    "label": 1
                },
                {
                    "sent": "It's known that cathepsin L is involved in cleavage of the cooks.",
                    "label": 0
                },
                {
                    "sent": "One transcription factor and.",
                    "label": 0
                },
                {
                    "sent": "Their buys accelerate accelerating progression into the S phase of the cell cycle.",
                    "label": 0
                },
                {
                    "sent": "Cathepsin L has also been reported to be.",
                    "label": 0
                },
                {
                    "sent": "Processing or proteolytically processing.",
                    "label": 0
                },
                {
                    "sent": "The end terminal tail of histone three during mouse embryonic stem cell differentiation.",
                    "label": 0
                },
                {
                    "sent": "So it's really interesting this this sort of combination of cystatin B nucleus and cathepsin L in the new clothes and what is what is the function of.",
                    "label": 0
                },
                {
                    "sent": "Of this of Cystatin B and the new clothes.",
                    "label": 0
                }
            ]
        },
        "clip_27": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And here we just show from human cells that what I already said that this is the patient who is homozygous for their daughter, repeat and has about 10% of the of the.",
                    "label": 0
                },
                {
                    "sent": "Expression of cystatin B Arney level and protein level and then.",
                    "label": 0
                },
                {
                    "sent": "Here is a patient with with the stop codon mutation that seems to have less than.",
                    "label": 0
                },
                {
                    "sent": "Big expression on protein level.",
                    "label": 0
                }
            ]
        },
        "clip_28": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Then of course, if we want to study, study them.",
                    "label": 0
                },
                {
                    "sent": "I don't see it here.",
                    "label": 0
                },
                {
                    "sent": "Study the disease mechanisms we need.",
                    "label": 0
                },
                {
                    "sent": "Model and then Acutal published in 1998.",
                    "label": 0
                },
                {
                    "sent": "Mouse model forces that in.",
                    "label": 1
                },
                {
                    "sent": "Beware the mice.",
                    "label": 0
                },
                {
                    "sent": "The middle one is the affected 1.",
                    "label": 0
                },
                {
                    "sent": "Is sleeping and then is having this twitches?",
                    "label": 0
                },
                {
                    "sent": "And then is sort of catapulted into the air because of the Mayo clonus?",
                    "label": 0
                },
                {
                    "sent": "So it's three capital eights, the myoclonic phenotype in human patients.",
                    "label": 0
                },
                {
                    "sent": "In some aspects, it has my Kronos, but in demise it's during the sleep, whereas in human patients when they are active and when they're trying to do something, but they also have a progressive phenotype, they get progressive ataxia that becomes clinically evident at six months of age.",
                    "label": 0
                },
                {
                    "sent": "There have been some anecdotal.",
                    "label": 0
                },
                {
                    "sent": "Reports from human EPM on patients having benefited from antioxidant therapy, and we therefore wanted to see whether whether.",
                    "label": 0
                }
            ]
        },
        "clip_29": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Statin B at efficiency might be associated with oxidative stress, and I show some data from this, this and all the publication but.",
                    "label": 0
                },
                {
                    "sent": "So that we were able to see this is from cerebellar granule cell primary cultures.",
                    "label": 0
                },
                {
                    "sent": "We were able to show that in response to oxidative stress.",
                    "label": 0
                },
                {
                    "sent": "In the expression is is increased and then also be able to show that.",
                    "label": 0
                },
                {
                    "sent": "In these mice, cystatin B deficient mice they are sensitized to oxidative stress including induced cell death.",
                    "label": 1
                },
                {
                    "sent": "So they're they die more easily due to oxidative stress and we were able to show by rescue experiments that this was specific for cystatin B.",
                    "label": 0
                },
                {
                    "sent": "Fish.",
                    "label": 0
                }
            ]
        },
        "clip_30": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We also studied the Caps in B and we made a hypothesis that may be catching be would be mediating this because there had been also the publications from a double knockout mouse by services that in big SMB whether the apoptosis phenotype in there or cell death, phenotype in the mass was less severe in this double knockout mice and we were also able to show that that cathepsin B is expression is increased in response to oxidative stress and then also the.",
                    "label": 0
                },
                {
                    "sent": "Pepsin activity in this cerebellar granule cells is increased in response to oxidative stress and then with R and AI experiments we were able to show this was over expression of cathepsin B increased cell death and RNA I.",
                    "label": 0
                },
                {
                    "sent": "Based cell death in response to oxidative stress.",
                    "label": 0
                },
                {
                    "sent": "And then importantly, we were able to show that cathepsin BR and I was able to counteract the increased sensitivity to oxidative stress into induced cell death caused by cystatin B deficiency.",
                    "label": 0
                }
            ]
        },
        "clip_31": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We were also interested whether oxidative stress could incur oxidative damage in the in the in vivo in this patients mice and we did a Red X analysis when unable to find that the mice had decreased, so activity and also reduced levels of glutathione in and then increased oxidized to reduce glutathione in levels, implying that there is impaired oxygen oxidative.",
                    "label": 0
                },
                {
                    "sent": "Capacity in these cells.",
                    "label": 0
                },
                {
                    "sent": "And it's well known that oxidative stress and these free radicals can cause problems too.",
                    "label": 0
                },
                {
                    "sent": "Or damage DNA proteins or lipids.",
                    "label": 0
                },
                {
                    "sent": "And we also did study this one, but we didn't show any damage of DNA only or protest.",
                    "label": 0
                },
                {
                    "sent": "But we we saw in.",
                    "label": 0
                },
                {
                    "sent": "Increased lipid damage to lipids in mice at six months of age and this was progressive from two months onwards.",
                    "label": 0
                },
                {
                    "sent": "This an it was mainly in the only in the cerebellum, not in other parts of the brain regions.",
                    "label": 0
                },
                {
                    "sent": "And then they also had increased levels of this glutathione peroxidase activity, which is most likely an adaptive process to do this increased lipid damage.",
                    "label": 0
                },
                {
                    "sent": "So together these studies imply that.",
                    "label": 0
                },
                {
                    "sent": "Just then be deficiency increases cerebella susceptibility to oxidative damage and this is impaired by reflected by impaired oxidative capacity and compromised lipid integrity.",
                    "label": 0
                }
            ]
        },
        "clip_32": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Then about the pathology in the in the mice.",
                    "label": 1
                },
                {
                    "sent": "So I already told that the mice have.",
                    "label": 0
                },
                {
                    "sent": "Myoclonus at one month of age and a taxi at six months of age and what is.",
                    "label": 0
                }
            ]
        },
        "clip_33": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Interesting is that the earliest neuropathological finding that we see is that there is a microglia gliosis that becomes evidence already at P14.",
                    "label": 0
                },
                {
                    "sent": "And you can see here that P14 microglial have an activated phenotype at and what month they look very angry looking phagocytosis, microglia and then we have seen.",
                    "label": 0
                }
            ]
        },
        "clip_34": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "That as the Gliosis follows at about one month of age and then from.",
                    "label": 0
                }
            ]
        },
        "clip_35": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "One month on words, there is a progressive neuron loss.",
                    "label": 0
                }
            ]
        },
        "clip_36": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then we have done also DT MRI imaging in the brains of these mice and have been able to show the blue color implies white matter damage in the my.",
                    "label": 0
                },
                {
                    "sent": "So they have also white matter damage as.",
                    "label": 0
                }
            ]
        },
        "clip_37": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Patients, and then there is a significant volume loss, especially in the cerebellum.",
                    "label": 1
                },
                {
                    "sent": "So you can see that compared to the wild type at six months, the cerebellum is is severely diminished in size and in some sense this is reflecting the phenotype of the patients that were described in the past year.",
                    "label": 0
                },
                {
                    "sent": "They didn't have cystatin B at all, they had a very severe progressive microcephaly, so this is maybe modeling more that disease then.",
                    "label": 0
                },
                {
                    "sent": "EPN one disease.",
                    "label": 0
                },
                {
                    "sent": "But of course it's modeling system can be deficiency.",
                    "label": 0
                }
            ]
        },
        "clip_38": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So we have been interested in this micro gliosis feed.",
                    "label": 0
                }
            ]
        },
        "clip_39": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Taipan.",
                    "label": 0
                }
            ]
        },
        "clip_40": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And have done in vitro called in Inverted Vista culture at Macro Micro glia some studies and have been able to show that the maglaya expressed a lot of cystatin B compared to neurons and astrocytes, and it's also increased in response to LP S stimulus.",
                    "label": 0
                },
                {
                    "sent": "And then we have been able to show that they have altered chemical and release.",
                    "label": 0
                },
                {
                    "sent": "They're more chemo, tactically.",
                    "label": 0
                },
                {
                    "sent": "Active the mice from their cystatin B knockout microglia and then that there there is no significant in vitro significant decline in phagocytosis.",
                    "label": 0
                },
                {
                    "sent": "But maybe if you can say a tendency towards that.",
                    "label": 0
                }
            ]
        },
        "clip_41": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then we have done also.",
                    "label": 0
                },
                {
                    "sent": "Expression studies from the culture at microglia have been able to show that there is impaired signaling.",
                    "label": 0
                },
                {
                    "sent": "We interferon pathway.",
                    "label": 0
                }
            ]
        },
        "clip_42": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "In collaboration with the group in Spain, Amanda Sierra, who's done a lot of phagocytosis studies we have sent her the samples of these mice and she has been done.",
                    "label": 0
                },
                {
                    "sent": "These studies and she has been able to show that the mice already at P14 have increased of ptosis in the hippocampus and then they try to sort of compromise for the increased apoptosis by increasing the number of micro client but not enough in order to be.",
                    "label": 0
                },
                {
                    "sent": "Able to clear that there all the web dot Excel so that the phagocytosis in capacity of this Misys impaired.",
                    "label": 1
                },
                {
                    "sent": "So clearly there is a problem in the microglial phagocytosis function, which is important for developing neural networks and also sort of refining neural networks postnatally until about teenage years.",
                    "label": 0
                },
                {
                    "sent": "By synaptic pruning.",
                    "label": 0
                },
                {
                    "sent": "But that's still something that needs to be studied in more detail.",
                    "label": 0
                }
            ]
        },
        "clip_43": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We have characterized also the micro glia directly extracted from brace and have been shown that they are polarized to the proinflammatory phenotype.",
                    "label": 0
                },
                {
                    "sent": "They are more more pro inflammatory polarized.",
                    "label": 0
                }
            ]
        },
        "clip_44": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then that we have been able to show that with.",
                    "label": 0
                },
                {
                    "sent": "Various studies that there is increased inflammation in the brain that increased expression of many inflammatory markers that I think in the interest of time I'm not going into the.",
                    "label": 0
                }
            ]
        },
        "clip_45": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The test and then also there's an increased invasion of peripheral T lymphocytes and granulocytes in the brain.",
                    "label": 0
                },
                {
                    "sent": "And the Vascularisation is is increased.",
                    "label": 0
                },
                {
                    "sent": "But Interestingly, the blood brain barrier seems to be intact or still at P30H.",
                    "label": 0
                },
                {
                    "sent": "So there is.",
                    "label": 0
                },
                {
                    "sent": "Altered functional properties of microglia.",
                    "label": 0
                },
                {
                    "sent": "They react in an abnormal way which is resulting in inflammatory feel.",
                    "label": 0
                }
            ]
        },
        "clip_46": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Type in the brain.",
                    "label": 0
                },
                {
                    "sent": "Of course there is a brain phenotype, but then we have asked the question that.",
                    "label": 0
                },
                {
                    "sent": "Of course I'll show soon because of of Natasha's work as well.",
                    "label": 0
                },
                {
                    "sent": "That would the mice show also peripheral inflammatory features.",
                    "label": 0
                },
                {
                    "sent": "An interesting we found from the theorem of these mice that they had very many different site concept where increased in their serum.",
                    "label": 0
                },
                {
                    "sent": "This proinflammatory cytokines that Interestingly this sexy L13 seems to be one that was very highly.",
                    "label": 0
                },
                {
                    "sent": "Increased an also narne level from the MRI expression.",
                    "label": 0
                },
                {
                    "sent": "Studies that we had done previously.",
                    "label": 0
                },
                {
                    "sent": "We found a 29 increased expression of the gene for CXC 13 that seems to be sort of the hallmark of the microglial activation in these mice.",
                    "label": 0
                }
            ]
        },
        "clip_47": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "Then to work done in this Natasha's group.",
                    "label": 0
                },
                {
                    "sent": "So Natasha has been working on her group, has been working on a little bit different background what mouse mouse over than what we have.",
                    "label": 0
                },
                {
                    "sent": "But it's interesting that we have, even if the background is different, we have very similar findings in that.",
                    "label": 0
                },
                {
                    "sent": "First of all, she has been able to show that there is this.",
                    "label": 0
                },
                {
                    "sent": "The mice are more sensitive to LP's induced in the toxemia as shown shown here.",
                    "label": 1
                },
                {
                    "sent": "And then.",
                    "label": 0
                }
            ]
        },
        "clip_48": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Also, that MPs which is applying for LTC stimulus increases the pro inflammatory cytokines.",
                    "label": 0
                },
                {
                    "sent": "Instead, almost cystatin B mice and what's interesting is that when we didn't use any LP's induction in our minds, we were not able to see increased levels of Interleukin 1 beta so but but it was shown here so that you need an inflammatory stimulus in order to increase that.",
                    "label": 0
                },
                {
                    "sent": "Situation of interlocking one beat them.",
                    "label": 0
                }
            ]
        },
        "clip_49": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And finally.",
                    "label": 0
                },
                {
                    "sent": "From these peripheral or bone marrow derived macrophages that's been shown that there is altered inflammasome and interleukin 1 beta pathway activation in cystatin B.",
                    "label": 0
                },
                {
                    "sent": "My so that is shown by increased caspase 11 and caspase 10 expression and also increased processing of interleukin 1 beta.",
                    "label": 0
                },
                {
                    "sent": "So All in all there's clear signs that there is information.",
                    "label": 0
                }
            ]
        },
        "clip_50": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "That is playing role in the pathogenesis of EPM, one disease, and we have asked, well, is it a neurological disease, or is it an auto inflammatory disease?",
                    "label": 0
                },
                {
                    "sent": "And of course, this is something that we are not.",
                    "label": 0
                },
                {
                    "sent": "We don't have an answer yet too, but things are not as easy.",
                    "label": 0
                },
                {
                    "sent": "It's not only information, actually.",
                    "label": 0
                }
            ]
        },
        "clip_51": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "When I said that the earliest butter logical change, so neuropathological change that we saw was in P. 14 miles, but we have done also some electrophysiological studies from.",
                    "label": 0
                },
                {
                    "sent": "Arabella of P5 Post Natal Day five mice and studied the electrophysiological properties of perky sales.",
                    "label": 0
                },
                {
                    "sent": "And I'm not going into the details, but summarizing these findings is that already at P4, the cystatin B mice show alterations in this Cup magic signaling.",
                    "label": 0
                },
                {
                    "sent": "And they don't have.",
                    "label": 0
                },
                {
                    "sent": "Problems in the numbers of neurons interneurons at that time?",
                    "label": 0
                },
                {
                    "sent": "Yet, but they seem to have problems in the synaptic synapses or couple logic terminals, diminished, diminished in numbers.",
                    "label": 0
                },
                {
                    "sent": "And also there's reduced, like unbinding of Cafe receptors, implying that there might be a problem of this couple.",
                    "label": 0
                },
                {
                    "sent": "Jack inhibitory networks already early.",
                    "label": 0
                },
                {
                    "sent": "Early in the disease.",
                    "label": 0
                }
            ]
        },
        "clip_52": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "About the Genesis and this is our sort of current hypothesis, so we have, on the other hand micro glia neurons.",
                    "label": 0
                },
                {
                    "sent": "We also have astrocytes, but this we have not yet touched so.",
                    "label": 0
                }
            ]
        },
        "clip_53": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So the idea?",
                    "label": 0
                }
            ]
        },
        "clip_54": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Is that?",
                    "label": 0
                }
            ]
        },
        "clip_55": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We know that if cystatin beasts reduced in expression in microglia, you have altered functional properties and the increased secretion of inflammatory mediators and then, on the other hand it can result in altered neural excitability.",
                    "label": 0
                }
            ]
        },
        "clip_56": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then there is the vicious.",
                    "label": 0
                }
            ]
        },
        "clip_57": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Cycle that this altered neural network excitability leads to activation of micro.",
                    "label": 0
                }
            ]
        },
        "clip_58": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Why and then increased expression of?",
                    "label": 0
                }
            ]
        },
        "clip_59": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Probably inflammatory stimulators, neural damage there.",
                    "label": 0
                }
            ]
        },
        "clip_60": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And then more secretion of inflammatory triggers and.",
                    "label": 0
                }
            ]
        },
        "clip_61": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And it's it's this vicious cycle that keeps on going.",
                    "label": 0
                },
                {
                    "sent": "And if we would somehow could interfere with this one, that might be to the benefit of.",
                    "label": 0
                }
            ]
        },
        "clip_62": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Nations, then there's some words about the unifying pathological mechanisms that I promised to tell you in earlier in my talk.",
                    "label": 0
                },
                {
                    "sent": "So EPM one, and make the two diseases with different genetic basis, and then the primary defect, and then very similar.",
                    "label": 0
                },
                {
                    "sent": "The clinical and your physiological features.",
                    "label": 0
                },
                {
                    "sent": "So the unifying theme here is the Cup allergic networks or kojic interneurons and problems in those.",
                    "label": 0
                },
                {
                    "sent": "So so good, could this be the joint pathological mechanisms that the Copa ERGIC inhibition early on is his is impaired in in these diseases?",
                    "label": 0
                }
            ]
        },
        "clip_63": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So of course, patients hope for.",
                    "label": 0
                },
                {
                    "sent": "New medications and it's important that we work towards direction.",
                    "label": 0
                },
                {
                    "sent": "Although it's very important also to understand all the details and but I think at least the finished funders want that.",
                    "label": 0
                },
                {
                    "sent": "We do translation of these research and we want to find new treatments.",
                    "label": 0
                },
                {
                    "sent": "And of course should we try to focus on modulating specific neuro physiological system.",
                    "label": 0
                },
                {
                    "sent": "Of course I think it's more interesting, at least at this point is to direct the therapist to molecular lesions.",
                    "label": 0
                },
                {
                    "sent": "An for example I in general.",
                    "label": 0
                },
                {
                    "sent": "I can make and then also the modulation and inflammation and oxidative stress because if you be good.",
                    "label": 0
                },
                {
                    "sent": "Based on our hypothesis, diminish this oxidative stress information and then thereby affecting the neural excitability and then that would be.",
                    "label": 0
                },
                {
                    "sent": "Benefit beneficial for the patients, but then of course the timing of the treatment if the damage is done already very early or during the post Natal development, then we should be able to try to.",
                    "label": 0
                },
                {
                    "sent": "To attack the problem earlier and not in the symptomatic patients first.",
                    "label": 0
                },
                {
                    "sent": "Then of course, if we can also focus on downstream.",
                    "label": 0
                }
            ]
        },
        "clip_64": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Targets so very.",
                    "label": 0
                },
                {
                    "sent": "Quickly some conclusions.",
                    "label": 0
                },
                {
                    "sent": "I think I have convinced you that PMS is a clinically and genetically very heterogeneous group of diseases, and that's.",
                    "label": 0
                },
                {
                    "sent": "We can nowadays diagnose it in most cases and that we have tools in our hands that we can also maybe complete the molecular genetic spectrum of of PMS in the near years.",
                    "label": 0
                },
                {
                    "sent": "And that all has helped patients.",
                    "label": 0
                },
                {
                    "sent": "But of course we now need to focus on on translation at robotic approaches, which is not easy, for example, as exemplified in EPM, one that is a complex interplay with numerous Anglian affect in neural survival and involved in oxidative stress and inflammation.",
                    "label": 0
                },
                {
                    "sent": "So there's still much work to be done and I hope to be able to find something to help for the patients before I retire.",
                    "label": 0
                }
            ]
        },
        "clip_65": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And this is then acknowledgements my my my current group and my current collaborators and and the funding.",
                    "label": 0
                },
                {
                    "sent": "So thank you for your attention.",
                    "label": 0
                },
                {
                    "sent": "Thank you very much.",
                    "label": 0
                },
                {
                    "sent": "This was a very nice talk, so the paper is open for questions.",
                    "label": 0
                },
                {
                    "sent": "Thank you for excellent presentation, Angelina.",
                    "label": 0
                },
                {
                    "sent": "What I'm interesting is you mention patient that have that are homogeneous for Argentine 68 mutations.",
                    "label": 0
                },
                {
                    "sent": "Do they have more pro inflammatory phenotype that they have high inflammation?",
                    "label": 0
                },
                {
                    "sent": "Whether it's not known yet because they were they were published like as a clinical report.",
                    "label": 0
                },
                {
                    "sent": "So within the year.",
                    "label": 0
                },
                {
                    "sent": "So I think I should contact them and maybe ask for.",
                    "label": 0
                },
                {
                    "sent": "Fibroblast cell lines and we could do this.",
                    "label": 0
                },
                {
                    "sent": "I PS cells and then to have them because we have IPS cells from human EP and one patient, so it would be nice to have their Mesa to compare the different phenotypes including the inflammatory here.",
                    "label": 0
                },
                {
                    "sent": "But nothing is known about that yet.",
                    "label": 0
                },
                {
                    "sent": "Since you mentioned that they have problems with violation it.",
                    "label": 0
                },
                {
                    "sent": "Is it possible that is like in autoimmune diseases when you have destruction of myelin?",
                    "label": 0
                },
                {
                    "sent": "Yes, that's one possibility, but of course we don't know that we have been thinking because of course we saw so significant myelin loss in APL one.",
                    "label": 0
                },
                {
                    "sent": "Nations and then also the mouse with the parallel study.",
                    "label": 0
                },
                {
                    "sent": "So I've been thinking that it would be secondary to general death, so the nurse died so you don't need a white matter and it's it's it's cleared away.",
                    "label": 0
                },
                {
                    "sent": "But of course there is a possibility that there is also a development aspect there as well that it could be effective.",
                    "label": 0
                },
                {
                    "sent": "Hello hi, thank you for talk.",
                    "label": 0
                },
                {
                    "sent": "I have a question regarding the stop code on arginine and though the Camaro repeat you mentioned that in Finland.",
                    "label": 0
                },
                {
                    "sent": "Have patience with both mutations and they have severe problems.",
                    "label": 0
                },
                {
                    "sent": "However you also find in one case that only has stop codon mutation and that was the most severe form or basically lacking Steven B.",
                    "label": 0
                },
                {
                    "sent": "So what is the linkage here?",
                    "label": 0
                },
                {
                    "sent": "Because in the first case you have both mutations and it's not such a severe case.",
                    "label": 0
                },
                {
                    "sent": "As compared to that one.",
                    "label": 0
                },
                {
                    "sent": "OK, so maybe I wasn't clear enough in them in the.",
                    "label": 0
                },
                {
                    "sent": "In the case where you have.",
                    "label": 0
                },
                {
                    "sent": "2 copies of the Dodeca Mary repeat expansion.",
                    "label": 0
                },
                {
                    "sent": "You have maybe 10% of cystatin B expression left in your cells.",
                    "label": 0
                },
                {
                    "sent": "Then when you have one copy from one parent of the system in BDO decametric suppression expansion mutation, and then the stop codon mutation, how my hypothesis?",
                    "label": 0
                },
                {
                    "sent": "An hour data point to it that in that from that allele you don't get functional cystatin B at all, so that their level of cystatin B might only be 5% or even less, and then these patients that were published where they didn't have the expansion mutation at all, but they have only two.",
                    "label": 0
                },
                {
                    "sent": "2 copies or from both parents, the stop mutation.",
                    "label": 0
                },
                {
                    "sent": "They might not have any sister didn't be so that it would be like a threshold effort, but if you have some cystatin B, you get EPM one you have half of the sum.",
                    "label": 0
                },
                {
                    "sent": "You get more severe pain, one if you don't have any, you get another disease.",
                    "label": 0
                },
                {
                    "sent": "Well, to your explanation I would have the suggestion that if you do have an opportunity to have patients cells that you do try if there might be this gaining toxic function due to let's say aggregation of this protein when it is mutated.",
                    "label": 0
                },
                {
                    "sent": "But my question one is for the therapy, is it possible to change the gene?",
                    "label": 0
                },
                {
                    "sent": "Is that close to the clinic well?",
                    "label": 0
                },
                {
                    "sent": "Well.",
                    "label": 0
                },
                {
                    "sent": "In principle, I mean there are new methods coming all the time, so that would be also maybe the possibility that you have now this crisp.",
                    "label": 0
                },
                {
                    "sent": "I've kissed by glass technology that you could.",
                    "label": 0
                },
                {
                    "sent": "You might be able to delete the expansion mutation and have normal expression of cystatin B and that obviously is something that should be pursued.",
                    "label": 0
                },
                {
                    "sent": "You should only have a whole army of people working on the money of the whole Finnish government to do this, and that would be obviously a very interesting.",
                    "label": 0
                },
                {
                    "sent": "Excellent presentation it since you saw also.",
                    "label": 0
                },
                {
                    "sent": "Operations in motor function.",
                    "label": 0
                },
                {
                    "sent": "Did you saw any correlation with Parkinson's disease?",
                    "label": 0
                },
                {
                    "sent": "Do you mean?",
                    "label": 0
                },
                {
                    "sent": "Phenotypes that would be exactly because actually, I mean you you found also in Eugene, which shows also very similar phenotype to EPM wise, but now, maybe not not so much to Parkinson's disease, but but what has been discussed in EPM one is because it's usually, I mean, it's progressing microns epilepsy, because they have epilepsy.",
                    "label": 0
                },
                {
                    "sent": "As one of the vino ties.",
                    "label": 1
                },
                {
                    "sent": "But then the myoclonus is the most severe presentation, and so it's been also discussed that whether it's an epileptic phenotype because in many cases, when you have Mayo clonus, you can see the EG.",
                    "label": 1
                },
                {
                    "sent": "That there is a corresponding e.g.",
                    "label": 0
                },
                {
                    "sent": "Change that so that it would be an epileptic myoclonic between many patients.",
                    "label": 0
                },
                {
                    "sent": "You don't see they can have a very severe myoclonic sort of attack and then you take each.",
                    "label": 0
                },
                {
                    "sent": "You don't see anything and that implies that you get the Maya clones from deeper structures.",
                    "label": 0
                },
                {
                    "sent": "That would be more like maybe Parkinson like, but more like a movement disorder.",
                    "label": 0
                },
                {
                    "sent": "They're like, yeah yeah.",
                    "label": 0
                },
                {
                    "sent": "But if you see, for example, I mean, you see the patient instability.",
                    "label": 0
                },
                {
                    "sent": "When you see the tremors which add features which are pretty much in common with Parkinson's disease, yes, I'm not a clinician seeing myself, but I know that there is in the old literature.",
                    "label": 0
                },
                {
                    "sent": "It's always says that there's some trim or also, but I think it's.",
                    "label": 0
                },
                {
                    "sent": "The parents describe at least tremor, but it's a tremor.",
                    "label": 0
                },
                {
                    "sent": "Is it?",
                    "label": 0
                },
                {
                    "sent": "Mayo clonus?",
                    "label": 0
                },
                {
                    "sent": "Or is it a taxi?",
                    "label": 0
                },
                {
                    "sent": "It's very hard.",
                    "label": 0
                },
                {
                    "sent": "Then you need to really help, but I had to my understanding the patients they have this myoclonus that they have like a drop off of muscle tone suddenly and then they can have this a taxi.",
                    "label": 0
                },
                {
                    "sent": "That they cannot really, but that could be also partially due to to to my clonus, but the three more they don't really have, at least to my understanding, thank you.",
                    "label": 0
                },
                {
                    "sent": "Other more questions.",
                    "label": 0
                },
                {
                    "sent": "Concerning genetic diseases, I think we're still far away, especially gene replacement or whatever.",
                    "label": 0
                },
                {
                    "sent": "This is we are far away, but I think what's maybe more important people are concentrated when they discover one.",
                    "label": 0
                },
                {
                    "sent": "This is their constant.",
                    "label": 0
                },
                {
                    "sent": "It usually on one June, and what I think what is the future indeed to study much more deeply and other possibilities then?",
                    "label": 0
                },
                {
                    "sent": "Because there is some, I believe some cooperation between all this.",
                    "label": 0
                },
                {
                    "sent": "Genes and resulting proteins, of course.",
                    "label": 0
                },
                {
                    "sent": "And this my opinion might be.",
                    "label": 0
                },
                {
                    "sent": "Direction to the future.",
                    "label": 0
                },
                {
                    "sent": "We mean modifying genes, genes modifying the phenotype.",
                    "label": 1
                },
                {
                    "sent": "Yeah yeah, that's that's true.",
                    "label": 0
                },
                {
                    "sent": "And this is this is certainly something that should be.",
                    "label": 0
                },
                {
                    "sent": "We have also been thinking about that.",
                    "label": 0
                },
                {
                    "sent": "How should we do the problem?",
                    "label": 0
                },
                {
                    "sent": "Maybe with the rare diseases that they are rare and then most likely you will have many modifying genes.",
                    "label": 0
                },
                {
                    "sent": "So how would you have the statistical power to choose them?",
                    "label": 0
                },
                {
                    "sent": "But of course you could make some educated guesses about.",
                    "label": 0
                },
                {
                    "sent": "For example, the inflammatory phenotype, would you be able to like?",
                    "label": 0
                },
                {
                    "sent": "Study some candidate genes as modifying genes so, but this is certainly something that we need to work on.",
                    "label": 0
                },
                {
                    "sent": "For example, in EPM, one within the family, you can have a patient who is wheelchair bound and the patient who is walking so that they.",
                    "label": 0
                },
                {
                    "sent": "They have the same mutation that they have a very similar genetic background, but yet they have something that is different because their phenotype is very different and also in the mouse.",
                    "label": 0
                },
                {
                    "sent": "But I said that we are working with a different mouse background with Natasha, so we're working with this.",
                    "label": 0
                },
                {
                    "sent": "We 129 that has the Mayo Clinic, Savannah type at one month and then there is the early inflammatory phenotype.",
                    "label": 0
                },
                {
                    "sent": "But when we put the mutation into C 57 black background, we don't get Mayo clonus at least by four months of age.",
                    "label": 0
                },
                {
                    "sent": "We didn't look any further than that.",
                    "label": 0
                },
                {
                    "sent": "And that was also published by Pennacchio Tell and also the the.",
                    "label": 0
                },
                {
                    "sent": "If my microglial inflammation phenotype cause much more late and it's much less, it's less severe.",
                    "label": 0
                },
                {
                    "sent": "So that's one thing that we have been thinking that maybe we should.",
                    "label": 0
                },
                {
                    "sent": "With the mice we should try to map what is the.",
                    "label": 0
                },
                {
                    "sent": "What are the jeans that in or the jeans that make this difference?",
                    "label": 0
                },
                {
                    "sent": "Mouses mouse, but yet they have a very different and they have.",
                    "label": 0
                },
                {
                    "sent": "They have an inbred congenic background, so that might be one way of.",
                    "label": 0
                },
                {
                    "sent": "Going further.",
                    "label": 0
                },
                {
                    "sent": "Anymore questions.",
                    "label": 0
                },
                {
                    "sent": "I have the last question or another question from the general public, that's me.",
                    "label": 0
                },
                {
                    "sent": "So what is speech in this PME patients like?",
                    "label": 0
                },
                {
                    "sent": "So what is speech?",
                    "label": 0
                },
                {
                    "sent": "How do they?",
                    "label": 0
                },
                {
                    "sent": "How do they talk?",
                    "label": 0
                },
                {
                    "sent": "It's they have dysarthria.",
                    "label": 0
                },
                {
                    "sent": "It's sometimes when I have I give talks to them and then they ask me questions.",
                    "label": 0
                },
                {
                    "sent": "Sometimes it's very hard to.",
                    "label": 0
                },
                {
                    "sent": "To understand because they also have this Mayo clonus in their mouth.",
                    "label": 0
                },
                {
                    "sent": "So it's very hard to understand their speech many times if they have like you said, it happens, the seizures happen or the tremor happens when somebody wants to do something and speech is usually voluntary.",
                    "label": 0
                },
                {
                    "sent": "So yes, speeches is one thing.",
                    "label": 0
                },
                {
                    "sent": "It's they have.",
                    "label": 0
                },
                {
                    "sent": "It's very hard to.",
                    "label": 0
                },
                {
                    "sent": "Understand when many times what they're asking, especially if they're a little bit stressed about asking, then it becomes women were movers.",
                    "label": 0
                },
                {
                    "sent": "OK, thank you very much.",
                    "label": 0
                },
                {
                    "sent": "Thank you.",
                    "label": 0
                }
            ]
        }
    }
}